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 Proteins provide evidence that a given gene is expressed, and machine learning 
algorithms can be applied to various proteomics problems in order to gain information 
about the underlying biology.  This dissertation applies machine learning algorithms to 
proteomics data in order to predict whether or not a given peptide is observable by mass 
spectrometry, whether a given peptide can serve as a cell penetrating peptide, and then 
utilizes the peptides observed through mass spectrometry to aid in the structural 
annotation of the chicken genome.  Peptides observed by mass spectrometry are used to 
identify proteins, and being able to accurately predict which peptides will be seen can 
allow researchers to analyze to what extent a given protein is observable.  Cell 
penetrating peptides can possibly be utilized to allow targeted small molecule delivery 
across cellular membranes and possibly serve a role as drug delivery peptides.  Peptides 
and proteins identified through mass spectrometry can help refine computational gene 
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With the availability and advancement of rapid genome sequencing technology, 
an abundance of genomic sequence information is becoming available.  In addition, high-
throughput proteomics techniques rapidly generate large volumes of data useful for both 
protein identification and determining protein expression.  Since the amount of biological 
data available for research in the biological sciences is growing rapidly, new 
experimental and computational methods and tools must be developed to transform data 
into information.  Proteomics focuses on the study of proteins and peptides and the 
patterns of their expression and regulation within a given organism.  Proteins serve as the 
building blocks of life, and can serve as both structural entities and biochemical catalysts 
within living cells.  Given the rapidly increasing volume of proteomics data, 
computational techniques for mining and analyzing the data are needed.  Machine 
learning, a subfield within artificial intelligence, is routinely used in computational 
biology to derive models from large data sets and use these models to predict behavior of 
an experimental system. 
This dissertation applies machine learning and other computational techniques 1) 




penetration potential of peptides, and 3) to assist in the structural genome annotation of 
the genomes through a process termed proteogenomic mapping [1]. 
The first problem, the prediction of peptides detectable by mass spectrometry 
using machine learning algorithms, specifically examines the use of neural networks in 
the prediction of detectablility.  Published datasets from chicken bursa and lymphoma 
proteomics experiments were used as training and test sets for the machine learning 
classifiers.  This work has been published in BMC Bioinformatics[2]. 
The second problem, the prediction of peptides capable of penetrating cellular 
membranes using machine learning algorithms, adapts the features from the prediction of 
MS peptide dectectability and utilizes these properties in conjunction with support vector 
machines to predict cell penetration potential.  A literature search of known cell-
penetrating peptides, along with known cell-penetrating peptides available from 
commercial vendors was used to create data sets for training and testing the support 
vector machines.  A subset of peptides predicted to be cell-penetrating and non-
penetrating were synthesized and utilized for experimental validation of the classifier 
using avian eukaryotic tissue culture systems in conjunction with fluorescence 
microscopy and fluorescent quantitative uptake analysis.  This work has been submitted 
for publication in PLOS Computational Biology and the manuscript is in revision. 
The third problem, using peptides observed by mass spectrometry to assist in the 
structural annotation of genomes through proteogenomic mapping, has been investigated 
using the Gallus gallus genome.   Proteogenomic mapping uses peptides detected from 




methods based on computational gene prediction and EST/cDNA libraries.  Mapping the 
peptides to the genome,  provides evidence for new functional genomic units that 
traditional methods often fail to identify.  Recent findings from the ENCyclopedia Of 
DNA Elements (ENCODE) project [3] show that the human genome is more active than 
previously believed, with a significant portions of the genome being pervasively 
transcribed.  Given this pervasive transcription, it is likely that some of these transcripts 
are translated into protein.  Proteogenomic mapping can reveal which of these transcripts 
are expressed at the protein level. A paper describing the proteogenomic pipeline has 
been accepted for publication in BMC Bioinformatics.  A paper describing the results of 
proteogenomic mapping with chicken serum is in preparation. 
The remainder of this chapter briefly introduces the three problems in more detail 
and provides an overview of the relevant literature.  More in-depth discussions of the 
relevant literature are included in subsequent chapters along with the research approaches 
and methodologies, and results.  
 
 
Prediction of Peptide Properties 
 
The primary amino acid sequences of peptides have been used to calculate and 
infer a number of properties of peptides such as mass, isoelectric point, secondary 
structure , etc..  These properties can, in turn, be used by machine learning algorithms to 
construct classifiers to predict additional peptide properties such as the observability of a 






Peptides Observability by Mass Spectrometry 
 
In high-throughput non-electrophoretic proteomics, complex mixtures of proteins 
are subjected to proteolytic digestion with an enzyme such as trypsin before the 
fragments are separated by liquid chromatography (LC) and analyzed by tandem mass 
spectrometry.  However, for a particular protein, only a portion of the peptides are 
actually observed experimentally and the set of peptides that are observed from a single 
protein can vary substantially from one experiment to another.  A number of factors 
contribute to lack of detection of some peptides and to variations in the peptides detected 
from one experiment to another.  These include incomplete proteolytic digestion, small 
size, poor binding or elution from the type of LC column used, mass range limitations of 
the mass spectrometer, bias for detecting peptides with an intense MS signal in mixtures, 
the phenomenon of ―ion suppression‖, the charge prior to ionization, and non-covalent 
interactions between peptides in the gas phase while in the mass spectrometer [4].   There 
are also substantial differences in the peptides observed due to experimental variations in 
protein extraction and/or solublization methods, tissue types, prefractionation, LC 
separation conditions, and differences between gradients even when the same LC 
separation conditions are used.  Furthermore, different databases, different search 
software and even different versions of the same software also influence which peptides 
are detected.   
We refer to peptides that can be detected as ―flyable‖.  The fact that most proteins 
in a complex mixture are represented by only a small number of proteolytic peptides 




assessment of the level of confidence in protein identifications [6], determining the 
peptide coverage of proteins [7], determining if ―missing‖ proteins are potentially 
observable [8, 9], and using peptide observability as an adjustment factor for protein 
quantification based on observed peptides [7, 10].   Recently reported methods for 
predicting peptide observability have been based on large training datasets from multiple 
experiments dealing with a single organism [7, 10].  However, because the observability 
of peptides depends not only on the properties of the peptides themselves but also on 
specific experimental, instrumental, and analytical procedures, we contend that it is 
necessary to provide a method for predicting peptide observability for a specific 
experimental set at the local level.  This ability to construct a classifier for a particular 
dataset is particularly important for researchers who work in smaller laboratories, deal 
with a variety of organisms and/or tissues, employ a variety of protein extraction 
protocols, and/or who use a centralized facility for proteomics where they have little 
control over instrumental and analytical protocols. 
We describe a method for constructing a classifier for a proteomics data set that 
can predict peptide observability for a particular set of experimental conditions.  We 
demonstrate that the classifiers constructed using this method provide critical information 
for assessing the validity of protein identifications and valuable evidence to support 
competing hypotheses about the presence or absence of ―missing‖ proteins in a pathway 
of interest.   
The set of tryptic peptides that are observed under experimental conditions can be 




experimentally observable peptides that can be used to uniquely identify a protein, while 
flyable peptides are all peptides that are experimentally observable but may not be 
proteotrypic [11].  Proteotypic peptides are a subset of flyable peptides and flyable 
peptides are a subset of all possible tryptic peptides.  The spectra generated by mass 
spectrometry analysis of a complex peptide mixture are matched against theoretical 
spectra generated from an in silico trypsin-digested protein database.  The resulting set of 
peptide identifications is then used for protein identification. Detection of at least one 
proteotypic peptide is required for protein identification.   
There is, however, disagreement among researchers about the number of peptide 
matches and the peptide coverage of the protein that are required for a protein 
identification to be considered valid.  Protein identifications based on a single proteotypic 
peptide (sometimes called ―one hit wonders‖) are often viewed with skepticism.   Some 
researchers contend that a protein identification needs at least two proteotypic peptides to 
be valid, while others contend that a single high quality peptide can be used for 
identification purposes [6].  Furthermore, some proteins produce only one proteotypic 
peptide.  In addition to the number of peptides identified, the degree of coverage of the 
protein by peptides may also be used as a measure to assess the validity of the 
identification—this is typically provided in terms of the percentage of amino acids in the 
protein ―covered‖ by identified peptides.   However, an additional and more meaningful 
statistic is the percentage of potentially detectable peptides that are observed.  This 




proteotypic peptides for identification and can prevent loss of important data [6] or the 
inclusion of erroneous identifications.   
Two other research groups have described methods for the prediction of peptide 
detection using mass spectrometry, but their methods are distinct from ours.  Mallick et 
al. [7]  have compiled a large training set from multiple yeast proteomics experiments 
and built Gaussian mixture discriminant function predictors for a number of different 
proteomics platforms.  Their goal is to characterize the general properties of peptides that 
can be detected using different proteomics technologies, to determine the coverage of the 
predicted proteome that is detectable using different technologies, and they also argue 
that their method can be used to improve protein quantification.  Lu et al. [10] describe a 
classifier for predicting peptide observability that is a component of a method for 
absolute protein quantification and that adjusts scores for protein abundance based on the 
predicted detectability of in silico generated tryptic peptides. 
 
 
Cell Penetrating Peptides 
Cell penetrating peptides (CPPs), also referred to as ―Trojan‖ peptides, protein 
transduction domains, or membrane translocation sequences, are typically hydrophobic 
linear arrangements of 8-24 amino acids able to cross the lipid bi-layer membrane that 
serves as the cell’s outer barrier and gain access to the interior of the cell and its 
components [12].  Penetratin, an Antennapedia derived peptide, and the HIV derived Tat 
peptide were some of the first commonly studied CPPs, and along with transportan 
peptides (derived from galanin receptor ligand proteins), make up three major families of 




Cell penetrating peptides capable of transporting other active molecules inside the 
cell have the potential to serve as drug delivery peptides.  Although there is some 
controversy regarding CPPs as drug delivery systems because of their lack of specificity 
for cell type, the general consensus among researchers is that both general CPPs and cell-
specific CPPs will be developed into effective drug delivery systems in the future [13, 
14].  A classification system that can determine whether or not a peptide can serve as a 
CPP can enable researchers to quickly screen candidate molecules for their potential 
viability for use in a customizable drug delivery regime.   
Much of the previous work in the prediction of CPPs has involved the use of a set 
of composite features assembled from primary biochemical properties through the use of 
principal component analysis [15-17].  These composite features, or z-scores, consist of a 
numerical value and an associated range.  To predict cell-penetrating capability of a 
candidate peptide, the z-scores are computed for the peptide, and, if the z-scores fall 
within the range of known CPP z-scores, the peptide is classified as cell-penetrating [16, 
17].  While this method has a high accuracy (>95% correct prediction of novel CPPs) for 
generating novel  CPPs [16], it performs rather poorly (68% correct prediction) when 
trying to distinguish known non-penetrating peptides that are closely related to known 
CPPs [17] and yields little information about exactly which biochemical properties 
contribute to the difference between these two classes.   More recent work examines the 
use of quantitative structure-activity relationship (QSAR) derived features to predict 
penetration potential.  The training process iteratively removes sequences that are 




Further research into this topic is necessary to allow potential drug delivery peptides to be 
rapidly screened for usefulness. 
Using the basic biochemical properties of peptides as features instead of 
composite z-scores can potentially provide more insight into the differences between the 
class of CPPs and non-penetrating peptides when coupled with the use of a machine 
learning classifier such as a support vector machine.  Additionally, once trained, these 
machine learning classifiers can then be used for rapid screening of candidate CPPs prior 




Structural genome annotation is the process of identifying all of the structural 
elements that comprise an organism’s sequenced genome.  These structural elements can 
include regions that code for proteins, both coding and non-coding RNAs, regulatory 
regions, and DNA binding motifs.  Traditionally, this has been accomplished through the 
use of expressed sequence tags (ESTs) and cDNA libraries, transcribed RNA that is 
reverse translated into DNA sequences.  These ESTs and cDNAs generally represent 
approximately 500-800 base pair mRNA sequences that are sequenced as they are, or 
translated back into cDNA and then sequenced [19, 20].  These EST and cDNA libraries 
are then aligned with the sequenced genome to identify regions representing exons and 
whole genes that are actively transcribed [19, 20]. 
These library based-methods are typically complemented by the use of 
computational gene finders.  The computational gene finders use the EST and cDNA 




known as homology based computational annotation [19, 20].  Some programs can also 
perform de novo based genome annotation where they detect signal information within 
the genome and use these signals to predict coding regions [19].   Computational gene 
prediction tools are known to produce a number of errors and significant resources are 
dedicated to identifying and correcting these errors in genome annotation projects [19, 
21].  It has been estimated that the exact genomic structure is only correctly identified by 
computational gene finders 50-60% of the time within the human genome, the most well 
sequenced and annotated genome [21].   Both homology-based methods and de novo 
methods are effective for identifying new genetic sequences similar to known genes or 
with known signals.  However, these methods are ineffective for identifying new genes 
with limited sequence similarity or signal information [19].   The use of high throughput 
proteomics, in conjunction with the genome sequence, has the potential to provide 
additional evidence for new genes or corrections to the boundaries of known genes.   
The use of high throughput shotgun proteomics data derived from mass 
spectrometry experiments is increasingly being used as a complementary method for 
structural genome annotation [22].  This use of proteomics data to aid in genome 
annotation began around 2001[23] for several prokaryotic projects, and was popularized 
in 2004 by Jaffe et al., who coined the term proteogenomic mapping [1].  Proteomic 
evidence, identified as expressed Protein Sequence Tags (ePSTs), provides proof that a 
given gene is expressed, and when back translated and aligned with the sequenced 
genome, provide structural annotation information for a genome’s functional elements 




identification of gene and exon boundaries, evidence for post translational processing, 
identification of splice-forms including alternative splicing, and also, the prediction of 
completely novel genes” [22].  Since the development of proteogenomic mapping, it has 
been utilized in a number of both prokaryotic [1, 23, 25-31] and eukaryotic [9, 32-42] 
genome annotation projects, and is increasingly becoming a part of standard annotation 
pipelines utilizing multiple sources of evidence (sequenced nucleic acids, computational 





This dissertation uses proteomics data combined with machine learning tools to 
contribute to the prediction of peptide properties and to improve the structural annotation 
of the chicken genome. The dissertation demonstrates the use of proteomics data and 
machine learning to solve three different bioinformatics problems.  The remainder of this 
dissertation reviews the relevant literature of the three proteomics problems, describes 
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PREDICTION OF PEPTIDES OBSERVABLE BY MASS SPECTROMETRY 







When proteins are subjected to proteolytic digestion and analyzed by mass 
spectrometry using a method such as 2D LC MS/MS, only a portion of the proteotypic 
peptides associated with each protein will be observed.  A number of factors can 
contribute to the inability to detect some peptides including protein extraction methods, 
choice of proteolytic enzymes, properties of the peptides, experimental and 
instrumentation conditions, non-covalent interactions by the peptides in the gas phase, 
and changes to database search algorithms.  The ability to predict which peptides can and 
cannot potentially be observed for a particular experimental dataset has several important 
applications in proteomics research including calculation of peptide coverage in terms of 








We have developed a methodology for constructing artificial neural networks that 
can be used to predict which peptides are potentially observable for a given set of 
experimental, instrumental, and analytical conditions for 2D LC MS/MS (a.k.a 
Multidimensional Protein Identification Technology [MudPIT]) datasets.  Neural network 
classifiers constructed using this procedure for two MudPIT datasets exhibit 10-fold cross 
validation accuracy of about 80%.   We show that a classifier constructed for one dataset 
has poor predictive performance with the other dataset, thus demonstrating the need for 
dataset specific classifiers.  Classification results with each dataset are used to compute 
informative percent amino acid coverage statistics for each protein in terms of the 
predicted detectable peptides in addition to the percent coverage of the complete 
sequence.  We also demonstrate the utility of predicted peptide observability for systems 
analysis to help determine if proteins that were expected but not observed generate 




Classifiers that accurately predict the likelihood of detecting proteotypic peptides 
by mass spectrometry provide proteomics researchers with powerful new approaches for 
data analysis.  We demonstrate that the procedure we have developed for building a 
classifier based on an individual experimental data set results in classifiers with accuracy 
comparable to those reported in the literature based on large training sets collected from 
multiple experiments.  Our approach allows the researcher to construct a classifier that is 
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specific for the experimental, instrument, and analytical conditions of a single experiment 
and amenable to local, condition-specific, implementation.  The resulting classifiers have 
application in a number of areas such as determination of peptide coverage for protein 




In high-throughput non-electrophoretic proteomics complex mixtures of proteins 
are subjected to proteolytic digestion with an enzyme such as trypsin before the 
fragments are separated by liquid chromatography (LC) and analyzed by tandem mass 
spectrometry.  However, for a particular protein, only a portion of the peptides are 
actually observed experimentally and the set of peptides that are observed from a single 
protein can vary substantially from one experiment to another.  A number of factors 
contribute to the inability to detect some peptides and to variations in the peptides that are 
detected from one experiment to another.  These include incomplete proteolytic 
digestion, small size, poor binding or elution from the type of LC column used, the 
limited mass range that can be detected by the mass spectrometer, bias toward detecting 
peptides with an intense MS signal in mixtures, the phenomenon of ―ion suppression‖, 
the charge prior to ionization, and non-covalent interactions between peptides in the gas 
phase while in the mass spectrometer [1].   In addition, there are substantial differences in 
the peptides observed due to variations in the protein extraction and or solublization 
methods, tissue types, prefractionation, LC separation conditions, and differences 
between gradients even when the same LC separation conditions are used.  Furthermore, 
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different databases, different search software and even different versions of the same 
software also influence which peptides that are detected.   
We refer to peptides that can be detected as ―flyable‖.  The fact that most proteins 
in a complex mixture are represented by only a small number of proteolytic peptides 
presents several difficulties for proteomics researchers [2].  These problems include 
assessment of the level of confidence in protein identifications [3], determining the 
peptide coverage of proteins [4], determining if ―missing‖ proteins are potentially 
observable [5, 6], and using peptide observability as an adjustment factor for protein 
quantification based on observed peptides [4, 7].   Recently reported methods for 
predicting peptide observability have been based on large training datasets from multiple 
experiments dealing with a single organism [4, 7].  However, because the observability of 
peptides depends not only on the properties of the peptides themselves but also on 
specific experimental, instrumental, and analytical procedures, we contend that it is 
necessary to provide a method for predicting peptide observability for a specific 
experimental set at the local level.  This ability to construct a classifier for a particular 
dataset is particularly important for researchers who work in smaller laboratories, deal 
with a variety of organisms and/or tissues, employ a variety of protein extraction 
protocols, and/or who use a centralized facility for proteomics where they have little 
control over instrumental and analytical protocols. 
Here we describe a method for constructing a classifier for a proteomics data set 
that can predict peptide observability for a particular set of experimental conditions.  We 
demonstrate that the classifiers constructed using this method provide critical information 
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for assessing the validity of protein identifications and valuable evidence to support 
competing hypotheses about the presence or absence of ―missing‖ proteins in a pathway 
of interest.   
The set of tryptic peptides that are observed under experimental conditions can be 
divided into two classes – proteotrypic and flyable.  Proteotrypic peptides are those 
experimentally observable peptides that can be used to uniquely identify a protein, while 
flyable peptides are all peptides that are experimentally observable but may not be 
proteotrypic [8].  Proteotypic peptides are a subset of flyable peptides and flyable 
peptides are a subset of all possible tryptic peptides.  The spectra generated by mass 
spectrometry analysis of a complex peptide mixture are matched against theoretical 
spectra generated from an in silico trypsin-digested protein database.  The resulting set of 
peptide identifications is then used for protein identification. By definition, detection of at 
least one proteotypic peptide is required for protein identification.   
There is, however, disagreement among researchers about the number of peptide 
matches and the peptide coverage of the protein that are required for an identification to 
be considered valid.  Protein identifications based on a single proteotypic peptide 
(sometimes called  ―one hit wonders‖) are often viewed with skepticism.   Some 
researchers contend that a protein identification needs at least two proteotypic peptides to 
be valid, while others contend that a single high quality peptide can be used for 
identification purposes [3].  Furthermore, some proteins produce only one proteotypic 
peptide.  In addition to the number of peptides identified, the degree of coverage of the 
protein by peptides may also be used as a measure to assess the validity of the 
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identification—this is typically provided in terms of the percentage of amino acids in the 
protein ―covered‖ by identified peptides.   However, an additional and more meaningful 
statistic is the percentage of potentially detectable peptides that are observed.  This 
information has the potential to increase (or decrease) the credibility of some single 
proteotypic peptides for identification and can prevent loss of important data [3] or the 
inclusion of erroneous identifications.   
Researchers using proteomics are interested in not only cataloging proteins 
present, but also in studying the location and differential expression of the proteins 
involved in biochemical pathways [2].  Often, one or more proteins referenced to 
participate in a canonical pathway are not observed in a proteomics dataset, but most 
other proteins in the pathway are present [5, 6].  Conversely, a protein that has never been 
identified in that pathway may be identified by a single proteotypic peptide.  In the first 
case, it is important to know whether these missing proteins generate a sufficient number 
of potentially observable proteotypic peptides to support identification under the specific 
experimental conditions or whether the protein truly appears to be absent.  In the second 
case, it is important to determine if a protein may reasonably be expected to be identified 
by only one peptide under the experimental conditions—an identification of a protein 
with a single peptide where the protein is predicted to produce many observable 
proteotypic peptides should be viewed with suspicion. 
Two recently published papers describe methods for the prediction of peptide 
detection using mass spectrometry, but their methods are distinct from ours.  Mallick et 
al. [4]  have compiled a large training set from multiple yeast proteomics experiments 
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and built Gaussian mixture discriminant function predictors for a number of different 
proteomics platforms.  Their goal is to characterize the general properties of peptides that 
can be detected using different proteomics technologies, to determine the coverage of the 
predicted proteome that is detectable using different technologies, and they also argue 
that their method can be used to improve protein quantification.  Lu et al. [7] describe a 
classifier for predicting peptide observability that is a component of a method for 
absolute protein quantification and that adjusts scores for protein abundance based on the 
predicted detectability of in silico generated tryptic peptides.   In contrast, our procedure 
is specifically developed for generating a classifier for a single data set to predict flyable 
peptides for a particular set of experimental conditions (biological sample, protein 
extraction protocol, mass spectrometric instrumentation, HPLC column type, database 
search algorithm and settings, etc.) and to be applied locally.  We demonstrate that the 
resulting classification provides valuable information with regard to peptide coverage of 
a protein and can assist the proteomics researcher in a systems analysis of the dataset. 
 
 
Results and Discussion 
 
We have developed a procedure for building a classifier to predict peptide 
flyability from a proteomics dataset.  The output of the protein identification algorithms 
for a proteomics dataset includes the proteins that were identified and the peptides that 
were used for each protein identification.  As Figure 2.1 illustrates, the classifier 
construction process includes selection of a set of observed and unobserved peptides for 
the training set, extraction of features to represent the peptides in the training set, 
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normalization of the feature values, feature subset selection, and training and testing of 
the classifier.   
 
Training Set Compilation Strategy 
 
The first step in the process is selection of a set of peptides for the training data set.  
The naïve approach is to use all observed peptides for the positive examples and all non-
observed in silico generated peptides from identified proteins for the negative examples.  
However, this approach ignores several complications that arise when processing 
proteomics datasets.  First, some of the ―observed‖ peptides will be false positive 
identifications.  The probability that a peptide is a false positive identification is greatly 
reduced if it is one of multiple peptides used to identify a protein since the probability of 
this occurring by chance is small [3].  Therefore, we limit the positive examples to the 
peptides associated with proteins that were identified using multiple unique peptides.  
Peptides chosen for negative examples are also limited to the set of proteins identified by 
multiple peptides.  However, selection of negative examples is also complicated by the 
fact that the number peptides observed for a protein is directly related to protein 
abundance in the sample.  Isotope-free quantification methods for proteomics datasets 
make use of the relationship between the number of peptides observed and protein 
concentration [9-12].  To avoid the problem of labeling peptides that were not observed 
as negative examples because they are associated with low abundance proteins, we have 
chosen to compile the negative examples from the proteins that were identified with the 
largest number of peptides.  Although this introduces a bias for peptides from abundant 
and large proteins, this strategy insures, to the extent possible, that the peptides used for 
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negative examples were present in sufficient quantity to be potentially observable.  We 
have developed the following procedure for selection of the training set to ensure that the 
peptides selected for the class of observable peptides are high confidence identifications 
and that the peptides selected for the negative examples are truly ―unobservable‖ under 
the specific experimental conditions.   
1. Rank the protein identifications by the number of peptides used in the identification 
and include only identifications based at least two distinct peptides. 
 
2. Retrieve the amino acid sequence for each of the proteins in step 1, perform in silico 
trypsin (or appropriate enzyme) digestion of the proteins, and compile a list of all 
predicted tryptic peptides of length greater than 6 amino acids (because this number 
gives a probability of the sequence identifying another sequence at random of 1 in 19
6
 
and which is reasonable for a eukaryote genome of around 4 billion base-pairs such as 
human).  
 
3. If a peptide is present in the experimental data, it is assigned a value of 1 and if it is 
not observed in the experimental data it is given a value of 0.  There will be many 
more with a value of 0 than with 1. 
 
4. The peptides labeled with a 1 in the previous step are used as the positive examples in 
the training set.  Suppose the size of this set is n.  In order assure that peptides used as 
negative examples were present in sufficient quantity for detection and to also help 
produce a balanced training set, we select the first n ―unobserved‖ peptides from the 
proteins ranked by the number of peptides used for identification. 
 
 
Feature Generation and Classifier Construction 
 
Our approach for generating features to represent each peptide in the training set 
uses both the features listed in Table 2.1 (called Feature Set 1) and features constructed 
using properties from the AAIndex [13].   The first set of features (see Table 2.1) 
includes basic properties of the peptide (e.g. mass and size) and features related to the 
amino acid composition of the peptide. The AA Index is a compilation in a set of tables 
of 544 different indices used to characterize amino acids.  It includes indices for wide 
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variety of characteristics of amino acids including hydrophobicity, participation in certain 
types of structures, etc.  A feature value was generated for each peptide for each index 
representing the sum of the index values for all amino acids in the peptide.  Combination 
of Feature Set 1 and the AAindex features results in a total of 596 features for each 
peptide.  Although this set includes a large number of redundant features, we have shown 
that using both sets as input for the feature selection process yields improved classifier 
performance over use of each feature set alone.  For example, with the avian bursal 
dataset described below, the 10-fold classification accuracy of neural networks built with 
the AAIndex features only is 72%, with Feature Set 1 only is 71%, and with both feature 
sets is 81%.  Because the values of the features cover a wide range of numeric values, 
NV normalization is used to make the numeric range of all features 0-1.  Feature subset 
selection is then performed to find the set of feature most relevant to the task of 
predicting flyability and to remove redundant and non-informative features.  We use a 
feature selection method that performs a greedy search through feature space to identify 
features based on the level of consistency with class values when the training data is 
compared to the entire set of attributes [14].  The reduced set of features is used to train 
the classifier.  A 3-layer neural network classifier is constructed with an input unit for 
each of the selected features, (i+1)/2 hidden units where i is the number of input units, 
and a single output unit.  The neural network is trained using the training set constructed 
with the strategy described above and tested using 10-fold cross validation.   Multilayer 
neural networks provide a robust method for learning a functional mapping from numeric 
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attribute values to a class value—in this case a mapping from numeric features describing 
the peptide to the classes ―observable‖ and ―unobservable.‖    
In order to demonstrate the utility of our approach, we have used the methodology 
described above to build classifiers for two different published MudPIT data sets:  1) an 
avian bursa of Fabricius data set consisting of 5198 proteins [6], and 2) a Hodgkin’s 
lymphoma model data set consisting of 3983 proteins [5].  The classifiers built using our 
procedure had 10-fold cross validation classification accuracies of 81% and 72% 
respectively.  Table 2.2 lists the features selected that best distinguish observed peptides 
from unobservable peptides for both datasets.  Table 2.3 reports the accuracy and 
confusion matrices for the neural networks for both data sets based on 10-fold cross 
validation.   
The features selected tend to be related to structural properties of the peptides.  
For example, consider the features selected for the avian bursa classifier.   Prolines tend 
to break alpha helices and prolines located adjacent to lysine or arginine also interfere 
with trypsin digestion.  Amino acids with small side chains such as glycine and alanine 
increase the flexibility of the peptide.  The charge, polarity, hydrophobicity, and the 
behavior of the peptide in solvent also influence flyability.   
Our classifiers achieved classification accuracies comparable to the rates reported 
by Mallick et al. [4] and Lu et al. [7] for much simpler yeast systems.  The accuracy 
statistics reported by Mallick et al. are difficult to compare to ours because they report 
specificity in terms of (1 - positive predictive ratio) where the positive predictive ratio is 
defined as (true positives/(true positives + false positives)) rather than the more 
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traditional true positive ratio (true positives/(true positives + false negatives).  Lu et al. 
report a 69% true positive rate for observed and a 90% true positive rate for non-
observed.  Note that it is possible to achieve an 82% true positive rate for the non-
observed class for their classifier by guessing non-observed in every case. In addition, 
they include very small peptides (3 -5 aa) in their analysis and we exclude peptides of this 
length from our study because of the high probability of random matches to multiple 
proteins and their lack of power as unique identifiers.  
In order to evaluate the importance of building classifiers that are specific for a 
particular dataset, we tested each of the classifiers above with the data used for training 
the other classifier (i.e. avian bursal classifier with Hodgkin’s lymphoma model data set 
as test set and vice versa).  The results (Table 2.4) demonstrate that there is a substantial 
loss of classifier accuracy when using a classifier trained with one data set to predict 
peptide observability with the other data set.  In both cases, the true positive rate 
(prediction of observability) decreased dramatically (almost to the level that would be 
achieved by random guessing).  These results are consistent with those reported by 
Mallick et al. [4] when a classifier trained with yeast data was used to predict 
observability with human data.  These results clearly demonstrate the need for classifiers 
to be trained for each experimental set. 
We use the two classifiers described above for the avian bursa dataset and the 
Hodgkin’s lymphoma model dataset to demonstrate the utility of the classifiers for 
calculating an informative peptide coverage statistic for proteins and for analysis of 
system’s biology datasets.   In Table 2.4 the sections in white show, for a subset of 
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proteins that were observed in the data, the total number of tryptic peptides generated by 
in silico tryptic digestion, the number observed, the number of peptides predicted to be 
detectable by each classifier, and the amino acid coverage both in terms of the total 
number of tryptic peptides and in terms of those predicted to be observable.   As 
expected, in most cases the amino acid coverage for peptides predicted to be detectable is 
higher, sometimes substantially higher, than the total amino acid coverage.  In general, 
this approach allows the researcher to determine how many peptides might reasonably be 
expected to be detected. 
We have also used the bursal neural network and the Hodgkin’s lymphoma model 
neural network to determine if proteins that are ―missing‖ from a pathway of interest are 
likely to be potentially observable.  The results are given in Table 2.5.  As McCarthy et 
al. [6] reported, most components of the programmed cell death pathway with known 
orthologs in chicken were observed in the avian bursa data set with the exception of the 
protein DR3.  The peptides produced by in silico tryptic digestion of DR3 (GI 
118106991) were used as input to our neural network for this data set.  As shown in 
Table 2.5 (yellow section), none of the peptides for this protein were predicted to be 
observable.  In contrast, for proteins that were observed, the average number of 
observable peptides was 5.   For the Hodgkin’s lymphoma model dataset, there were five 
proteins that we expected to observe because we have observed them using other 
methods in other experiments [15, 16] but we did not see them in this experiment (shown 
in yellow in Table 2.4).  The results in Table 2.5 show that none of the tryptic peptides 
for these proteins is predicted to be observable under the given experimental conditions 
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while a set of proteins of similar size that were observed were predicted to be observable.  
Although these results cannot be used to demonstrate conclusively that a protein does or 
does not exist in a data set, they can be used as one piece of evidence to confirm or refute 
a hypothesis about the presence of a protein under certain conditions and to plan further 




We present a procedure for constructing a classifier to predict which tryptic 
peptides in a protein are likely to be detectable by mass spectrometry for a specific set of 
experimental and instrumental conditions.  We demonstrate that it is possible to construct 
a classifier with accuracy comparable to those previously reported based on the 
accumulation of large training sets from multiple experiments.  We also show that a 
classifier constructed based on one dataset does not perform at an acceptable level when 
predicting observability for another dataset and thus it is necessary to construct  
classifiers that are specific for one set of experimental conditions. The resulting classifier 
provides researchers with a tool that can provide information about peptide coverage of 
proteins in terms of which proteins are likely to be detectable.  It can also be used as one 
line of evidence in a systems analysis to evaluate alternative hypotheses concerning 
proteins that were not observed but that were expected.  If the ―missing‖ protein 
generates many predicted detectable peptides but none were observed, then this provides 
additional probabilistic evidence of absence of the protein—a very difficult hypothesis to 
demonstrate conclusively.   The classifier allows researchers to distinguish between 
proteins that are not likely to be detected with the methodology versus proteins that were 
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not expressed in the biological system. Only by making this distinction is it possible to 







  Methods used to collect the biological samples, analyze the samples using mass 
spectrometry, and identify proteins are described in detail in[5] and [6].  All samples 
were analyzed by MudPIT using an LCQ Deca XP Plus IT mass spectrometer and 
database search was conducted using TurboSEQUEST (Bioworks Browser; 




Custom Perl scripts were written to extract the accessions of proteins and lists of 
peptides from Sequest output files, to query NCBI and download the protein sequences, 
to trypsin digest the proteins, to determine which peptides had been observed in the 
dataset, to select the positive and negative peptides for the data sets, and to compute the 
feature vectors for each peptide.   The software implements the rules for trypsin digestion 
described for the ExPASy PeptideCutter tool [17].  WEKA Explorer Version 3.4.10, a 
software package containing a collection of machine learning algorithms for data mining 
available at http://www.cs.waikato.ac.nz/ml/weka/ [14] was used for feature selection, 
and building and testing the classifier.    The software that generates a training set from a 
Sequest output file and a detailed readme describing how to generate classifiers for a 
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A LIST OF INITIAL FEATURES USED FOR CLASSIFIER CONSTRUCTION IN 
ADDITION TO AAINDEX FEATURES. 
 
Feature Subset 1 
Length of peptide 






Count of each amino acid (20 features) 
Percent composition of each amino acid (20 
features) 
Percent polar amino acids 
Percent positive amino acids 
Percent negative amino acids 
Percent hydrophobic amino acids 
  






DESCRIPTION OF FEATURES SELECTED FOR THE CLASSIFIERS BUILT FOR 
THE TWO DATASETS. 
 
Avian Bursa Dataset  




Percent polar amino acids 
Percent hydrophobic amino acids 
Percent positive amino acids 
Percent negative 
Size (Dawson, 1972) 
Optimized transfer energy parameter (Oobatake et al., 1985) 
Weights for beta-sheet at the window position of 5 (Qian-Sejnowski, 1988) 
Transfer free energy from oct to wat (Radzicka-Wolfenden, 1988) 
Information measure for C-terminal turn (Robson-Suzuki, 1976) 
Amphiphilicity index (Mitaku et al., 2002) 
 
Hodgkin’s Lymphoma Model Dataset 
Number of cysteine 
Signal sequence helical potential (Argos et al., 1982) 
Transfer free energy to surface (Bull-Breese, 1974) 
Normalized relative frequency of alpha-helix (Isogai et al., 1980) 
Normalized relative frequence of double bend (Isogai et al., 1980) 
Distance between C-alpha and centroid of side chain (Levitt, 1976) 
Retention coefficient in NAH2PO4 (Meek-Rossetti, 1981) 
Interior composition of amino acids intracellular proteins (Fukuchi-
Nishikawa, 2001) 










10-FOLD CROSS-VALIDATION ACCURACY BY CLASS FOR NEURAL 








rate Precision Recall 
ROC 
Area 
Avian Bursal Dataset  
Not observed 0.80 0.19 0.81 0.80 0.87 
Observed 0.82 0.20 0.80 0.82 0.87 
  
Hodgkin's Lymphoma Model Dataset 
Not observed 0.66 0.22 0.75 0.66 0.80 







ACCURACY BY CLASS FOR NEURAL NETWORKS GENERATED USING ONE 









rate Precision Recall 
ROC 
Area 
Avian Bursal Dataset training set, Hodgkins Lymphoma test set  
Not observed 0.71 0.46 0.61 0.71 0.70 
Observed 0.54 0.29 0.66 0.54 0.70 
  
Hodgkin's Lymphoma Model Dataset training set, Avian Bursa test set 
Not observed 0.81 0.41 0.81 0.73 0.73 








NUMBER OF TRYPTIC PEPTIDES PREDICTED TO BE OBSERVABLE FOR 





























Avian bursa data set 
5902793 20 2 10 9 45 33 
119359 50 5 9 15 30 21 
128413 16 2 11 3 18 14 
2119012 7 2 28 3 43 17 
17025728 16 2 6 7 44 20 
122000 6 4 33 0 0 0 
1762374 7 1 23 2 29 21 
1172808 13 1 6 4 30 19 
7512219 44 1 2 11 25 34 
104697 9 2 22 4 44 30 
118106991 12 0 0 0 0 0 
Hodgkin’s lymphoma model data set 
479367 34 1 3 5 15 11 
729629 18 2 14 11 61 43 
899264 13 1 10 4 31 21 
63544 48 2 2 6 13 15 
50750413 38 3 11 8 21 25 
45433516 26 0 0 0 0 0 
46048702 14 0 0 0 0 0 
125745137 9 0 0 0 0 0 
125745114 9 0 0 0 0 0 
45433516 26 0 0 0 0 0 
 
NOTE: 1) For the avian bursa dataset, 10 randomly selected observed proteins (in white) 
and the DR3 protein that was expected but not observed (in yellow). 2) For the Hodgkin’s 
lymphoma model dataset, 5 proteins that were observed in the pathway under 
consideration and 5 (in yellow) that had been observed using other methods in previous 















Cell penetrating peptides (CPPs) are those peptides that can transverse cell 
membranes to enter cells.  Once inside the cell, different CPPs can localize to different 
cellular components and perform different roles.  Some generate pore-forming complexes 
resulting in the destruction of cells while others localize to various organelles.  Use of 
machine learning methods to predict potential new CPPs will enable more rapid 
screening for applications such as drug delivery.  We have investigated the influence of 
the composition of training datasets on the ability to classify peptides as cell penetrating 
using support vector machines (SVMs). We identified 111 known CPPs and 34 known 
non-penetrating peptides from the literature and commercial vendors and used several 
approaches to build training data sets for the classifiers. Features were calculated from 
the datasets using a set of basic biochemical properties combined with features from the 
literature determined to be relevant in the prediction of CPPs.   Our results using different 
training datasets confirm the importance of a balanced training set with approximately 
equal number of positive and negative examples.  The SVM based classifiers have greater 
classification accuracy than previously reported methods for the prediction of CPPs, and 
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because they use primary biochemical properties of the peptides as features, these 
classifiers provide insight into the properties needed for cell-penetration.  To confirm our 
SVM classifications, a subset of peptides classified as either penetrating or non-
penetrating was selected for synthesis and experimental validation.  Of the synthesized 




Cell penetrating peptides (CPPs), also referred to as "Trojan" peptides, protein 
transduction domains, or membrane translocation sequences, are typically hydrophobic 
linear arrangements of 8-24 amino acids able to cross the lipid bi-layer membrane that 
serves as the cell’s outer barrier and gain access to the interior of the cell and its 
components [1].  Penetratin, an Antennapedia derived peptide, and the HIV derived Tat 
peptide were some of the first commonly studied CPPs, and along with transportan 
peptides (derived from galanin receptor ligand proteins), make up three major families of 
CPPs.  The remainder of CPPs are classified in a fourth, miscellaneous family [1]. 
Initially, cellular uptake of CPPs was believed to be through endocytosis or 
protein transporters, but some evidence suggested the mechanism may involve direct 
transport through the lipid bi-layer of the cell, which takes into account the hydrophobic 
properties of most of these peptides [2].   The current view is that CPP internalization is 
accomplished predominantly by endocytosis  [3].  Historically, both flow cytometry and 
fluorescence microscopy have been used to study the uptake of CPPs into cells. Care 
must be used with these methods to avoid artifacts because traditional methodologies for 
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these techniques can incorrectly show a high concentration of CPPs localizing to the cell 
nucleus or a higher than actual concentration of CPPs being taken into the cell [2].   
Cell penetrating peptides capable of transporting other active molecules inside the 
cell have the potential to serve as drug delivery peptides.  Drug delivery peptides and 
CPPs allow researchers to probe the mechanisms of peptide transport across a lipid bi-
layer membrane and may allow customizable drug therapies for differing types of cells. 
Although there is some controversy regarding CPPs as drug delivery systems because of 
their lack of specificity for cell type, the general consensus among researchers is that both 
general CPPs and cell-specific CPPs will be developed into effective drug delivery 
systems in the future [4, 5]. 
A classification system that can determine whether or not a unique peptide 
sequence can serve as a CPP, and thus possibly be a potential drug delivery peptide, can 
enable researchers to quickly screen candidate molecules for their potential viability for 
use in a customizable drug delivery regime.   
Much of the previous work in the prediction of CPPs has involved the use of a set 
of composite features assembled from primary biochemical properties through the use of 
principal component analysis [6-8].  These composite features, or z-scores, consist of a 
numerical value and an associated range.  To predict cell-penetrating capability of a 
candidate peptide, the z-scores are computed for the peptide, and, if the z-scores fall 
within the range of known CPP z-scores, the peptide is classified as cell-penetrating [7, 
8].  While this method has a high accuracy (>95% correct prediction of novel CPPs) for 
generating novel  CPPs [7], it performs rather poorly (68% correct prediction) when 
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trying to distinguish known non-penetrating peptides that are closely related to known 
CPPs [8] and yields little information about exactly which biochemical properties 
contribute to the difference between these two classes.   More recent work examines the 
use of quantitative structure-activity relationship (QSAR) derived features to predict 
penetration potential.  The training process iteratively removes sequences that are 
difficult to classify and thus the classification accuracies reported are biased [9].   Further 
research into this topic is necessary to allow potential drug delivery peptides to be rapidly 
screened for usefulness. 
Using the basic biochemical properties of peptides as features instead of the 
widely used composite z-scores can potentially provide more insight into the differences 
between the class of CPPs and non-penetrating peptides when coupled with the use of a 
machine learning classifier such as a support vector machine.  Additionally, once trained, 
these machine learning classifiers can then be used for rapid screening of candidate CPPs 
prior to their synthesis.  This study examines the available information on known CPPs 
and their non-penetrating analogs in order to compile datasets used for training and 
testing of support vector machine classifiers using primary features derived from 
biochemical properties of each peptide and evaluates the accuracy of these classifiers.  
An experimental validation study was performed to determine the effectiveness of these 







Results and Discussion 
 
The goal of this study was to develop a machine learning approach for rapid 
screening of potential CPPs.  We use features representing primary biochemical 
properties directly rather than using a transformation such as PCA that combines multiple 
features into a single composite feature as reported by others [6-8].  In addition, we have 
investigated the best approach for constructing training datasets when there is a large 
disparity in the number of positive and negative examples.  Previous research has shown 
that unbalanced datasets are problematic when constructing classifiers [10]. We first 
identified known CPPs and known non-penetrating peptides from the literature to serve 
as positive and negative examples and calculated a number of primary biochemical 
properties for each of these peptides.  We then explored a number of different approaches 
for addressing the problem of unbalanced datasets and evaluated classification accuracy 
with the different approaches.  A wrapper based feature selection method was utilized to 
reduce the number of features needed for classification while providing insight into the 
biochemical properties necessary to distinguish CPPs from non-CPPs.  We have used 
support vector machine classifiers because of their ability to linearly separate classes in a 
high dimensional feature space. Classifier accuracy on our training sets was assessed 
using 10-fold cross validation and then each classifier was tested again using the 
unbalanced test set assembled from the literature.  In order to experimentally validate 
these results, a dataset of 250 peptides was created using a 0
th
 order Markov model based 
on the predicted chicken proteome [11], and these peptides were classified as either 
penetrating or non-penetrating by our classifier.  Subsets of both predicted penetrating 
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and predicted non-penetrating peptides were selected from these classification results and 
were synthesized.    Experimental validation of cell penetration capability was then 
determined using fluorescence microscopy and the quantitative uptake of peptides shown 
to be penetrating was performed. 
 
Dataset Construction Approaches 
Because of the sensitivity of classifiers to unbalanced classes [10], our first 
challenge was to generate datasets for training and testing.  A set of 111 known CPPs 
were identified from the literature [7, 8, 12].  However, only 34 negative examples could 
be found and many of these are analogs of known CPPs [7, 8]. Unbalanced datasets 
present a number of different problems for machine learning methods [10].  When only a 
comparatively small number of examples are available for one class, the machine 
learning algorithm will not have sufficient information to learn a function to distinguish 
the classes.  Reporting of classification accuracy is also impacted by unbalanced datasets.  
For example, if a dataset of 100 peptides contains 80 CPPs and 20 non-CPPs, a 
classification accuracy of 80% can be obtained by classifying all peptides as positive.  
Most previous work in CPP prediction has ignored this problem [8, 9].   
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We designed an experiment to investigate the effect of unbalanced datasets on CPP 
prediction and to find methods to address the problem to evaluate classifier accuracy with 
precision.  For the CPP prediction problem, there are many more positive examples than 
negative examples available. Five different approaches were used to generate training 
datasets for investigating this issue:  
   
1. Unbalanced:  Composed of 34 known negative examples and 111 known positive 
examples. 
 
2. Balanced with random peptides as negative examples. 111 random peptides were 
generated using a 0
th
 order Markov chain based on the chicken proteome and 
combined with 111 known positive examples.  All random peptides were assumed 
to be non-penetrating.  This approach is based on the assumption that the 
probability of randomly generating a CPP sequence is very small. 
 
3. Balanced with biological peptides as negative examples.  All chicken peptides of 
length 12-26 AA were downloaded from NCBI and a sample of 111 was drawn 
without replacement.  All were assumed to be non-penetrating.  This approach 
assumes that most biological peptides are non-CPP and the probability of drawing 
a CPP from this set is extremely low. 
 
4. Balanced by sampling known negatives. Random sampling with replacement from 
the 34 known negatives was used to yield a set of 111 negative examples that was 
combined with the 111 positive examples.  
 
5. Balanced by sampling known positives. Random sampling with replacement from 
the 111 known positive examples to yield a set of 34 positive examples that was 





The performance of all classifiers on the training data sets is based on 10-fold 
cross validation.  The confusion matrices for classifiers trained using datasets based on 
approaches 1-4 are shown in Table 3.1 and the classifier statistics are shown in Table 3.2.  
The classifier trained on the unbalanced dataset (111 positive examples and 34 negative 
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examples) has a classification accuracy of only 75.86% compared to the naïve approach 
of classifying all examples as positive which would result in a classification accuracy of 
76.55%.  The results for this dataset in Table 3.1 show that the resulting classifier 
predicts almost all examples to be positive.  This highlights the problems encountered 
when using an unbalanced dataset.  The classifier cannot distinguish positive and 
negative examples because the dataset contains so many more positive examples than 
negative examples and because many of the negative examples are analogs of the 
positives.    
The classifiers trained using both the dataset balanced with random peptides  for 
negatives (approach 2) and with biological peptides for negatives (approach 3) had 
classification accuracies of 95.95% and 94.14% respectively, indicating that both 
classifiers exhibit a high degree of accuracy in discriminating between known cell-
penetrating peptides and randomly generated or biological peptides assumed to be 
negative.  The confusion tables for these classifiers on the training data sets (Table 3.1) 
show that most of the mistakes are false negatives (CPPs incorrectly classified as non-
CPPs). The weakness of these training approaches is that some of the assumed negative 
examples may in fact be cell penetrating and known non-cell penetrating analogs of CPPs 
were not used as negative examples.  When we used these trained classifiers to evaluate 
the known non-penetrating cell penetrating analog peptides (our unbalanced test data set) 
these classifiers obtained accuracies of 80.69% and 79.31% respectively.  For both 
classifiers, approximately one third of the known non-penetrating peptides are classified 
as cell-penetrating.  Most of the mistakes made by these two classifiers on the test data 
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seem to be false positives, that is classifying a peptide with no cell penetrating potential 
as a CPP, and this classification of known non-penetrating cell penetrating analogs 
demonstrates that while these classifiers are very accurate distinguishing the features 
strongly predictive of cell penetrating potential from the vast majority of non-penetrating 
peptides, the features used for classification do not serve to distinguish between peptides 
more similar to CPPs that do not penetrate and those peptides that can act as CPPs.   
The classifier trained on the data set constructed using approach 4 (random 
sampling with replacement from the known negative examples) has a classification 
accuracy of 88.74% on the training data set when evaluated with 10-fold cross validation.  
When compared to the classification accuracy of the dataset generated using the 
unbalanced dataset, these results show that it is possible to classify a set of CPPs and a set 
of known non-penetrating peptides using our SVM based method when care is used to 
construct balanced datasets.   Table 3.2 shows that 60% of the errors are false positives 
(non-CPPs incorrectly classified as CPPs).  When we evaluated the unbalanced test set on 
this classifier, an accuracy of 91.72% was obtained. The classifiers trained on the smaller 
datasets using approach 5 have an average classification accuracy of 78.82% using 10-
fold cross validation.   
Approach 2  using randomly selected biological peptides as the negative examples 
gives the best 10-fold cross validation accuracy while approach 4 with random selection 
from the negative examples gives the best accuracy for the unbalanced training set.  This 
suggests use of a two step process for screening.  In the first step, a classifier trained with 
random biological peptides as the negative examples would be used for preliminary bulk 
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screening.  As a second step, peptides predicted to be CPP in step 1 would be screened by 
a classifier trained using approach 4 that is more accurate in distinguishing non-
penetrating analogs from CPPs.   Approach 4 also provides more insight into the rational 
design of novel CPP analogs as the negative examples used in this approach are generally 
constructed by the modification of a known CPP sequence.    
In Hällbrink et al. (2005), the authors describe a method of CPP prediction based 
on scoring a candidate peptide according to z-score descriptors, features compiled 
through PCA, and report an 84.05% accuracy in the prediction of 53 CPPs and 16 non-
functional CPP analogs [7].  A follow-up to this study, utilizing both more known CPPs 
(65) and more non-functional CPP analogs (20), reports a 68% prediction efficiency 
using the same z-score descriptor based prediction method [8].  More recently, these z-
score descriptors were utilized alongside quantitative structure-activity relationship 
features in an artificial neural network (ANN) to predict cell penetrating potential for a 
set of 101 peptides (77 CPPs, 24 non-penetrating CPP analogs) and report a classification 
accuracy of 83% for the general ANN model constructed [9]. However, it should be 
noted that the data set utilized is composed of unbalanced classes, and an accuracy of 
76.24% can be achieved by classifying every peptide encountered as a CPP.  A 
comparison of these previously published prediction methods and our approach is 
presented in Table 3.3.  The models constructed using our approaches and their high 
classification accuracies indicate that using the primary biochemical properties of a 
peptide as features instead of synthesized feature values compiled using PCA allows for a 
more informative analysis of which properties determine whether a given peptide is cell-
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penetrating.  Our approach also allows predictive models constructed on training sets to 
be used for more rapid and elucidative screening of cell-penetrating potential than 
previous predictive methods based on verifying whether a given peptide falls within some 
average range of composite features.   
For each classifier constructed, feature selection was conducted using a scatter 
search approach through feature space [13] where the “wrapped” classifier was the same 
type of SVM used for classifier construction.  The classifier is a sequential minimal 
optimization SVM [14] using the Pearson Universal Kernel [15].   Table 3.4 lists the 
features selected for datasets 1-4 above.  Because the number of training/testing samples 
for dataset 5 was so small, we generated ten different datasets using this approach.  The 
features selected from these ten datasets are listed in Table 3.5.  The features selected for 
the datasets constructed using approaches 1-5 contain a number of properties previously 
shown to aid in the prediction of CPPs.  These include net charge, positive charge, 
negative charge, the net donated hydrogen bonds, and the water-octanol partition 
coefficient.   The low number of features selected for the datasets constructed using 
approach 5 indicates over-fitting of these small datasets by the classification algorithm.  
Therefore our detailed examination of features selected focused on datasets generated 
using approaches 1-4.    The primary amino acid composition features, the number of a 
given amino acid and the percent a given amino acid contributes to the whole peptide 
sequence, indicates no predictive function arising from the non-polar amino acids leucine 
and isoleucine, the polar amino acid glutamine, and the negatively charged amino acid 
glutamate.  At least one of the amino acid composition features was selected for the 
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remaining amino acids, with the most notable of these being the positively charged amino 
acids lysine, arginine, and histidine, and the negatively charged amino acid aspartate.  In 
addition, the group of aromatic amino acids were selected to a notable degree, and the 
presence of some aromatic amino acids in the peptide sequence has been previously 





To experimentally validate our feature selection methodology and classifiers, 250 
random peptides were generated using a 0
th
 order Markov model based on the chicken 
predicted proteome and were classified as penetrating or non-penetrating using the 
classifier trained on the dataset constructed using random peptides as negative examples.  
From these classifications, four peptides predicted to be cell-penetrating and two peptides 
predicted to be non-penetrating were selected for synthesis and FITC-labeling along with 
three known cell penetrating peptides used for positive controls, three peptides consisting 
respectively of only polar amino acids, only non-polar amino acids, and only of mixed 
polar and non-polar amino acids to serve as negative controls.  In addition, a known non-
penetrating peptide (TP13, a transportan analog [16]) was selected for synthesis to serve 
as a minor validation for our set of known non-penetrating peptides. 
 
Cellular Internalization Microscopy Array of FITC-Labeled Peptides  
 
The uptake of synthesized FITC-labeled peptides was examined using an avian 
system to validate both our wrapper based feature selection methodology and SVM-based 
approach to predicting CPPs.  The results of our fluorescence microscopy analysis are 
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shown in Figure 3.1.  All peptides predicted to be cell-penetrating (Peptide-1 through 
Peptide-4) by our classifier were confirmed to be cell-penetrating.  Of our two negative 
predictions, Peptide-5 was confirmed to be a non-penetrating peptide while Peptide-6 was 
shown to traverse cellular membranes.  TP13, a CPP analog previously shown to be non-
penetrating in Bowes’ melanoma cells is clearly cell-penetrating peptide in our avian 
model. 
 
Uptake Quantification of FITC-Labeled Peptides 
 
To evaluate the relative uptake of our synthesized peptides and to provide a 
secondary confirmation of the fluorescence microscopy results, a quantitative uptake 
study was conducted using both quail SOgE cells and chicken embryonic fibroblasts.  
The results of the quantitative uptake study are shown in Figure 3.2.  Peptides 1-4 were 
shown to be CPPs, while Peptide-5 was correctly predicted to be non-penetrating.  
Peptide-6, which was predicted to be non-penetrating, was shown to traverse the 
membranes of both CEF and SOgE cells.  TP13, previously shown to be non-penetrating 
in melanoma cells, is again shown to have penetrated both CEF and SOgE cells to a high 
degree relative to both our positive controls and our predicted cell-penetrating peptides. 
TP13 was chosen as a non-penetrating CPP analog based on its non-CPP classification in 
a study examining the effects of deletion on a known CPP, transportan (TP) [16].  TP13 
was created by a deletion from the N-terminus and middle of the TP molecule and these 
deletions abolished the internalization of TP13 into Bowes’ melanoma cells.  All 
transportan-derived peptides that internalized during the original TP analog study 
contained tyrosine and 3 positive charges in their sequences, while those peptides without 
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tyrosine or one positive charge in the C-terminal portion of the peptide did not internalize 
[16].  TP13 contains tyrosine and 3 positive charges, meeting the criteria outlined by the 
original study for penetration and both our fluorescent microscopy data and quantitative 
fluorescent uptake data indicates that it does penetrate both SOgE cells and CEF cells. 
Peptide-6 (HSPIIPLGTRFVCHGVT) was predicted to be a non-CPP by our 
classifier, but was shown to internalize into both SOgE and CEF cells experimentally 
both by fluorescence microscopy and the quantitative uptake studies.  This peptide 
contains 3 positively charged amino acids along with phenylalanine.  The Sommets, et al. 
study examining TP and its derivatives states that all their peptides with 3 positive 
charges and tyrosine internalized, and as phenylalanine only lacks the hydroxyl group of 
the tyrosine molecule, this could contribute to the internalization of Peptide-6. The 
positive examples in our training data contain predominantly arginine and lysine as 
positive residues, while this peptide contains two histidine residues.   
  Our research shows that using the primary biochemical properties of peptides as 
features instead of composite features determined through the use of PCA can provide 
both more informative features and higher classification accuracies when using support 
vector machines for the classification of a given peptide as cell-penetrating.  The lack of a 
comprehensive and coherent database of cell-penetrating peptide data for bioinformatics 
analysis has been noted previously [8], and the majority of CPP studies have been 
conducted using a variety of different cell lines and detection techniques, making it 
difficult to unify these results.  Our results showing that a previously reported non-
penetrating analog of transportan is a CPP in our avian system confirms the need for a 
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large dataset of biologically confirmed positive and negative examples from a single 
biological system using a single detection methodology.  Until such a resource is 
available, the predictive capability of classifiers is difficult to assess. Our results also 
show that there may be classes of peptides that act as CPPs in a variety of cells and others 
that are more specialized.  Therefore, peptides designed to target delivery to specific cells 
and tissues of interest should be screened using a variety of cell lines.  Additionally, our 
results indicate there may be positional preference for certain types of amino acids such 
as positive charges and aromatic.  Further research should examine the effects of these 
positional effects. 
 
Materials and Methods 
 
 
Data Set Compilation Strategy 
 
A database of cell-penetrating peptides was constructed from the literature and 
from commercial vendor product lines [7, 8, 12].  A total of 111 cell-penetrating peptide 
(CPP) sequences were identified and used to create a database of positive examples 
(Table 6) [7, 8, 12].  The average amino acid lengths of these CPPs ranged from 12 to 26.  
Because very few peptides have been experimentally validated to be non-penetrating, it 
was more challenging to construct a database of negative examples.  Five different 
strategies were used.  Because our experimental system is avian, we have used the 
composition of the chicken proteome as the basis for two of our datasets.   Previous 
research has demonstrated the importance of using a balanced training sets where there 
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are approximately equal numbers of positive and negative examples  [10].   Our strategies 
are listed below: 
 
1. BALANCED WITH RANDOM PEPTIDES:  The set of 111 know CPPs 
was balanced with a  set of 111 peptides constructed using a 0
th
 order 
Markov chain derived from the IPI chicken proteome (ipi.CHICK.v3.56 
[11]) .  The peptide lengths were uniformly distributed in the range 12-26.  
We assume that there is a very low probability that randomly generated 
peptides would be cell penetrating.  
 
2. BALANCED WITH BIOLOGICAL PEPTIDES:  The set of 111 know 
CPPs was balanced with randomly selected biological peptides.  A set of 
411 chicken peptides from NCBI with lengths in the range 12-26 was 
downloaded.  Subsets of 111 peptides were selected randomly without 
replacement to provide multiple balanced datasets.   This dataset provides 
a set of positive examples of known CPPs and assumed negative examples 
of biological peptides of the same relative molecular size.  We assume that 
most naturally peptides are not cell penetrating. 
 
3. UNBALANCED USING ONLY KNOWN POSITIVES:   A set of 34 known 
non-penetrating cell penetrating peptide analogs and peptide hormones 
previously used as negative examples was constructed from a search of the 
literature and are listed in Table 3.7 [7, 8].  This dataset provides a set of 
known cell-penetrating positive examples and a set of non-penetrating 
peptides that have been experimentally shown not to traverse cellular 
membranes.   
 
4. BALANCED BY SAMPLING KNOWN NEGATIVES:  In order to produce a 
balanced dataset of both known non-penetrating peptides and known CPPs 
a set consisting of all 111 known cell penetrating peptides and 111 known 
non-penetrating cell penetrating analogs was constructed by selecting with 
replacement from the set of 34 known non-penetrating analogs . 
 
5. BALANCED BY SAMPLING KNOWN POSITIVES:  Subsets of the known 
CPPs of size 34 were selected with replacement and combined with the 34 








Feature Construction and Normalization 
 
For each dataset, we generate a set of basic biochemical properties of each peptide 
(e.g. mass, size, charge, secondary structure, etc) and other features previously shown to 
be useful in the prediction of CPPs (e.g. steric bulk and net donated hydrogen bonds) [8].  
The full list of the initial 61 features is shown in Table 3.8.  We use these features 
directly in our machine learning algorithm rather than using composite features such as 
features derived by principle component analysis [8, 17].  We feel this approach will be 
more informative in the rationale design of CPPs cell penetrating peptides. Because the 
data values for each feature within a dataset vary greatly, NV normalization was used to 
scale the numeric range of all features in the range [0,  1] [18].    
 
Machine Learning Software 
 
The WEKA Machine Learning Toolkit Version 3.6.1, a freely available software 
package containing a number of machine learning algorithms for data mining, was used 




We conducted feature selection to reduce the dimensionality of the feature 
vectors.  Empirical evaluation of a number of different feature selection methods was 
conducted and the best performance was obtained using a wrapper-based method.  The 
wrapper-based method uses a parallel scatter search algorithm [13] to evaluate feature 
subsets based on classifier performance.   Scatter search is an evolutionary algorithm, but 
unlike other evolutionary algorithms (e.g. genetic algorithms), the search for a local 
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optimum is guided through the use of a reference set that acts to intensify and diversify 
the resulting features [13].  Local searches of features generated from the reference set 
are conducted, and informative and diverse features from these local searches are used to 
update the reference set until a terminating condition is met [13].   
 
 Classifier Construction 
 
Our classifier is a support vector machine (SVM) trained via a sequential minimal 
optimization (SMO) algorithm used in conjunction with the Pearson VII universal kernel 
[14, 15].  SVMs are supervised learning classifiers generally used for solving two class 
problems, and in their simplest form can be thought of as a classifier separating two 
classes mapped onto a 2-dimensional plane by generating a line through the plane that 
optimizes the distribution of each class on either side of the line [14].  The SMO 
algorithm is a modification to the original SVM learning algorithms that replaces a 
numerical quadratic programming step with an analytical quadratic programming step, 
allowing the algorithm to spend a greater portion of time on the decision function instead 
of the quadratic programming step.  This greatly increases the speed of the SVM for 
classification and allows scaling for large datasets [14].   We chose to utilize SMO-based 
SVM classifiers because of their speed and performance for our two class problem of 
determining if given peptide is cell-penetrating or non-penetrating.  A kernel function 
used in conjunction with an SVM allows the classifier to examine non-linear 
relationships between features by mapping the initial non-linear features into a highly 
dimensional space where the solution can be represented by a linear classification [15].  
We chose the Pearson VII universal kernel (PUK) for our SMO-based SVM because 
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PUK has been shown to provide either equal or better mapping than traditional SVM 
kernels, while serving as a robust and generic alternative to other kernel functions [15].  




  A 0
th
 order Markov chain based on the amino acid frequency of the IPI Chicken 
Proteome (ipi.CHICK.v3.56) [11] was used to generate 250 peptides.  The classifier 
trained on our biologically based random peptide dataset was then used to classify each 
of these peptides.  From these classification results, four peptides predicted to be cell 
penetrating and two peptides predicted to be non-cell penetrating were selected for 
synthesis and experimental validation.  In addition, three peptides known to be cell-
penetrating (HIV-Tat [20], Antennapedia [21], and Pep-1 [22]) were chosen to be 
positive experimental controls.  Three other peptides, one of all polar amino acids, one of 
all non-polar amino acids, and one of a mix of polar and non-polar amino acids, were 
chosen as negative experimental controls because their lack of charged and aromatic R-
groups make it unlikely they would cross a cellular membrane.  One peptide (TP13 [8, 
16]) was randomly selected for synthesis from the list of known non-penetrating cell 
penetrating peptide analogs.  All peptides selected for synthesis are shown in Table 3.9.   
Peptides were synthesized (>95% purity) and N-terminally labeled with FITC, a 
fluorescent tag, by Biomatik.  During the peptide synthesis, one of our chosen negative 
controls, negative-2 (GLALLGIAVAILVVL-NH2) was unable to be synthesized to our 
desired purity levels due to insolubility issues and is not considered further.  The 
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lyophilized peptides were reconstituted using 1 mL of 4:1 dd H2O sterile filtered 0.45 µm 




Two avian cell lines, Quail SOgE muscle cells [23] and a primary culture of 
Chicken embryonic fibroblasts (CEF), were grown in tissue culture flasks in Dulbecco’s 
minimal essential medium containing 10% fetal bovine serum with penicillin (200 
IU/mL), streptomycin (200 µg/mL), amphotericin B (0.5 µg/mL) (MP Biomedicals), and 
non-essential amino acids at  37°C in a 5% CO2 atmosphere. 
 
 
Quantitative Uptake Analysis 
 
Approximately 100,000 cells per well (both CEFs and SOgEs) were plated onto 
12-well tissue culture plates approximately 2 days prior to the experiment and allowed to 
reach confluency.  The cells were changed to serum free media and incubated for 60 
minutes prior to experimentation.  The cells were then washed with two 1 mL washes of 
PBS, after which they were exposed to 300 µL of 10 µM peptide in serum free media for 
30 minutes, with three replicates per peptide per cell line.  The cells were then washed 
with two 1 mL washes of PBS, and lightly trypsinated to facilitate their detachment from 
the plate.  Cells were then lysed with 250 µL of 0.1% Triton-X in PBS at 4° C for 10 
minutes.  A 100 µL aliquot of the cell lysate and a 100 µL aliquot of the 10 µM peptide 
in serum free media were pipetted onto a 96-well plate.  Fluorescence was measured on a 
Dynex Fluorolite 1000 plate reader at 485/530nm. The samples were compared to the 
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fluorescence of the added amount of peptide and t-tests (p > 0.05) were performed for 
each experimental sample against an untreated control. 
 
Cellular Internalization Microscopy Array of FITC-Labeled Peptides 
 
The SOgE cells were seeded onto glass tissue microscopy slides (approximately 
50,000 cells/well), and allowed two days to reach confluency.  The cells were changed to 
serum free media and incubated for 60 minutes prior to experimentation.  The cells were 
then washed with two 1 mL washes of PBS, after which they were exposed to 300 µL of 
10 µM peptide in serum free media for 30 minutes.  The cells were then washed with two 
1 mL washes of PBS, and then fixed using UltraCruz
TM
 Mounting Medium (Santa Cruz 
Biotechnology) containing a DAPI nuclear stain.  The fluorescence was examined using a 
Nikon Eclipse TE2000-U Inverted Research Microscope with the MetaMorph 
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CONFUSION MATRICES FOR DATASETS GENERATED USING DIFFERENT 
APPROACHES. 
 Dataset 1.  Unbalanced (total examples 145). 
Non-
CPP 
CPP  Classified as 
0 34 Non-CPP 
1 110 CPP 
 
Dataset  2.  Balanced with random peptides as negatives. 
  A.  10-fold cross-validation with training data (total examples 222).
Non-
CPP 
CPP  Classified as 
109 2 Non-CPP 
 7 104 CPP 
 
  B.  Tested on unbalanced data (total examples 145). 
Non-
CPP 
CPP  Classified as 
12 22 Non-CPP 











TABLE 3.1 continued 
Dataset 3.  Balanced with biological peptides as negatives. 
  A. 10-fold cross-validation with training data (total examples 222). 
Non-
CPP 
CPP Classified as 
108 3 Non-CPP 
10 101 CPP 
 
  B. Tested on unbalanced data (total examples 145). 
Non-
CPP 
CPP  Classified as 
10 24 Non-CPP 
6 105 CPP 
 
Dataset  4.  Balanced by sampling known negatives. 
  A. 10-fold cross-validation with training data (total examples 222). 
Non-
CPP 
CPP  Classified as 
96 15 Non-CPP 
10 101 CPP 
 
  B. Tested on unbalanced data (total examples 145). 
Non-
CPP 
CPP  Classified as 
29 5 Non-CPP 








CLASSIFIER PERFORMANCE WITH DIFFERENT TRAINING REGIMES.   
a.  Performance from ten-fold cross validation with training data sets. 













Accuracy 75.86% 95.94% 94.14% 88.73% 78.82% 
True Positive 
Rate 
0.759 0.959 0.941 0.887 0.7883 
False Positive 
Rate 
0.768 0.041 0.059 0.113 0.2117 
ROC 0.495 0.959 0.941 0.887 0.7883 
*- These values represent the averages for 10 datasets. . 
b.      Performance of each classifier with original dataset. 









Accuracy 75.86% 80.69% 79.31% 91.70% 
True Positive 
Rate 
0.759 0.807 0.793 0.917 
False Positive 
Rate 
0.768 0.508 0.553 0.127 
























77.27% 67.44% 83.16% 75.86% 80.69% 79.31% 91.72% 
CPP 
Accuracy 
88.46% 80.30% 92.21% 99.10% 94.59% 94.59% 93.69% 
Non-CPP 
Accuracy 








FEATURES SELECTED FOR DATASETS GENERATED  
USING APPROACHES 1-4. 
 
Dataset 1 
(Balanced with random 
negative examples) 
Dataset 2 
(Balanced with biological 





(Balanced by random 
sampling of known negatives 
with replacement) 
Net Charge Net Charge Net Charge Negative Charge 
Positive Charge Isoelectric Point Positive Charge Isoelectric Point 
Number of serines (S) Molecular Weight Number of alanines (A) Number of glycines (G) 
Number of aspartates (D) Hydropathicity Number of arginines (R) Number of alanines (A) 
Percent valine (V) Number of valines (V) Percent arginines (R) Number of tryptophans (W) 
Percent proline (P) Number of lysines (K) Net Donated Hydrogen 
Bonds 
Number of asparagines (N) 
Percent phenylalanine (F) Number of arginines (R)  Number of lysines (K) 
Percent threonine (T) Percent glycine (G)  Number of histidines (H) 
Percent asparagine (N) Percent methionine (M)  Number of aspartates (D) 
Percent tyrosine (Y) Percent tyrosine (Y)  Percent  phenylalanine (F) 
Percent cysteine (C) Percent cysteine (C)  Percent tryptophan (W) 
Percent arginine (R) Percent aspartate (D)  Percent arginine (R) 
Percent histidine (H) Percent negative  Percent histidine (H) 
Percent aspartate (D) Water Octanol Partition 
Coefficient 
 Percent Hydrophobic 
Percent negative Net Donated Hydrogen 
Bonds 
 Percent negative 
Steric Bulk Percent Helix  Hydrophobicity 
Net Donated Hydrogen 
Bonds 
Percent Coil  Water Octanol Partition 
Coefficient 
Percent Helix    








FEATURES SELECTED FOR TEN DATASETS GENERATED USING APPROACH 5 
– BALANCED SUBSETS OF CPPS SAMPLED WITH REPLACEMENT COMBINED 
WITH KNOWN-CPP ANALOGS. 
Dataset 1 Dataset 2 Dataset 3 Dataset 4 Dataset 5 Dataset 6 Dataset 7 Dataset 8 
Dataset 
9 Dataset 10 
Number (V) Length Number (R) 
Net 
Charge Net Charge 
Percent 







Percent (R) Net Charge Percent (W) 
Negative 




Charge Number (G) 
Number 














































   
Percent (H) 
  










KNOWN CELL-PENETRATING PEPTIDES FROM THE LITERATURE AND 
COMMERCIAL VENDORS. 





AAVLLPVLLAAP [8, 12] 



















GRKKRRQRRRC [7, 8] 
GRKKRRQRRRPPC [7, 8] 
GRKKRRQRRRPQ [7, 8] 
GRQLRIAGKRLEGRSK [7] 
GWTLNPAGYLLGKINLKALAALAKKIL [7, 8] 
GWTLNPPGYLLGKINLKALAALAKKIL [7, 8] 
GWTLNSAGYLLGKINLKALAALAKKIL [7, 8, 12] 
GWTLNSAGYLLGKINLKALAALAKKLL [7, 8] 





KALAKALAKLWKALAKAA [7, 8] 






KITLKLAIKAWKLALKAA [7, 8] 
KIWFQNRRMKWKK [8] 
KLAAALLKKWKKLAAALL [7, 8] 





TABLE 3.6 continued 
KLALKLALKALKAALK [7, 8] 
KLALKLALKALQAALQLA [8] 












LLIILRRRIRKQAHAHSK [7, 8] 
LNSAGYLLGKINLKALAALAKKIL [7, 8] 
LNSAGYLLGKLKALAALAKIL [8] 
MANLGYWLLALFVTMWTDVGLCKKRPKP [8] 


















RQIKIWFPNRRMKWKK [7, 8] 
RQIKIWFQNMRRKWKK [8] 
RQIKIWFQNRRMKWKK [7, 8, 12] 
RQIKIWFQNRRMKWKKLRKKKKKH [7] 




RRRRRRRRR [7, 8, 12] 
RRWRRWWRRWWRRWRR [8] 
RVIRVWFQNKRCKDKK [7, 8] 
RVTSWLGRQLRIAGKRLEGRSK [7] 
SWLGRQLRIAGKRLEGRSK [7] 







TABLE 3.6 continued 


















KNOWN NON-PENETRATING CELL-PENETRATING PEPTIDE ANALOGS AND 
PEPTIDE HORMONES. 









GWTLNSAGYLLGKFLPLILRKIVTAL [7, 8] 









KLALKALKAALKLA [7, 8] 
KLALKLALKALKAA [8] 
LLGKINLKALAALAKKIL [8] 
LLKTTALLKTTALLKTTA [7, 8] 
LLKTTELLKTTELLKTTE [7, 8] 
LNSAGYLLGKALAALAKKIL [7, 8] 

















A LIST OF INITIAL FEATURES USED FOR CLASSIFIER CONSTRUCTION. 
Feature Reference 
Length of peptide [24] 
Net charge of peptide [24] 
Positive charge [24] 
Negative charge [24] 
Isoelectric point (pI) [24] 
Molecular weight [24] 
Hydropathicity [25] 
Number of Each Amino Acid (20 features) [24] 
Percent composition of each amino acid (20 features) [24] 
Percent polar amino acids [24] 
Percent positive amino acids [24] 
Percent negative amino acids [24] 




Water-Octanol Partition Coefficient [25] 
Steric Bulk [25] 
Side chain bulk [8] 
Net donated hydrogen bonds [8] 
Percent α helix [28] 
Percent random coil [28] 









PEPTIDES SYNTHESIZED FOR EXPERIMENTAL VALIDATION OF CLASSIFIER. 
Name Role Sequence (N to C) 
HIV-TAT [20] Control(+) YGRKKRRQRRR-NH2 
Antennapedia 





negative-1 Control(-) TCSSNCQTCPCSSNNCQ-NH2 
negative-2* Control(-) GLALLGIAVAILVVL-NH2 
negative-3 Control(-) PGNIQMMSVVSMSMTITN-NH2 
peptide-1 Predicted CPP FKIYDKKVRTRVVKH-NH2 
peptide-2 Predicted CPP RASKRDGSWVKKLHRILE-NH2 





peptide-5 Predicted Non-CPP FFSLPPVTQDWNSD-NH2 
peptide-6 Predicted Non-CPP HSPIIPLGTRFVCHGVT-NH2 






































High-throughput mass spectrometry (MS) proteomics data is increasingly being 
used to complement traditional structural genome annotation methods.  To keep pace 
with the high speed of experimental data generation and to aid in structural genome 
annotation, experimentally observed peptides need to be mapped back to their source 
genome location quickly and exactly.  Previously, the tools to do this have been limited 
to custom scripts designed by individual research groups to analyze their own data, are 
generally not widely available, and do not scale well with large eukaryotic genomes. 
 
Results 
The Proteogenomic Mapping Tool includes a Java implementation of the Aho-
Corasick string searching algorithm which takes as input standardized file types and 
rapidly searches experimentally observed peptides against a given genome translated in 
all 6 reading frames for exact matches.  The Java implementation allows the application 
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The Proteogenomic Mapping Tool provides a standalone application for mapping 
peptides back to their source genome on a number of operating system platforms with 
standard desktop computer hardware.  Researchers are provided with the options for 
selecting different genetic codes and selecting different methods for determining splice 
sites. The program executes very rapidly across a wide range of datasets and enables 




Expressed proteins provide experimental evidence that genes in the genome are 
being transcribed and translated to produce a protein product.  Recently, a new structural 
genome annotation method, proteogenomic mapping, has been developed that uses 
identified peptides from experimentally derived proteomics data to identify functional 
elements in genomes and to improve genome annotation [1-2].  Initially used for the 
structural annotation of prokaryotic genomes, proteogenomic mapping is rapidly gaining 
traction in eukaryotic genome annotation projects with larger genomes as a 
complementary method [3-4]. 
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Proteogenomic mapping can identify potential new genes or corrections to the 
boundaries of predicted genes by using peptide matches against the genome that do not 
match against the predicted proteome to generate expressed Protein Sequence Tags 
(ePSTs) [2].  When aligned with the genome and combined with the published structural 
annotation, these ePSTs are indicative of translation throughout the genome and can 
serve to supplement traditional structural genome annotation methods [3-5]. 
While a number of research groups are becoming increasingly active in the field 
of proteogenomic mapping [1-5], there is a lack of published and standardized tools to 
rapidly and exactly map identified peptides back to the genome translated in all 6 reading 
frames.  To our knowledge, there is only one comparable tool, PepLine [6], for 
proteogenomic mapping.  PepLine utilizes de novo based spectral identification based on 
short spectral match translations of 3-4 amino acids with flanking masses on either end 
for searches against the genome. In contrast, our tool enables the researcher to use the 
same database search algorithm and peptide validation approach for both protein 
identification and improved genome structural annotation.   
 
Implementation 
The Proteogenomic Mapping Tool is free to obtain and use, is written completely in Java, 
and is available for all common computer platforms.  It is licensed under GNU GPLv3 
making the source code available to the end user [7].  We provide both a command line 




Data Input and Customization 
The  GUI (Figure 1) takes three files as input from the user: a FASTA file of the 
peptides to be searched, a FASTA file containing the nucleic acid sequences the peptides 
are to be mapped against (typically the genome), and a file containing the genetic code to 
use based on the format of the National Center for Biotechnology Information’s (NCBI) 
toolkit for genetic codes [8].  Furthermore, FASTA output from the splice site prediction 
tool GeneSplicer [9] can optionally be provided.  If present, the splice sites given in that 
file are used instead of the default splice sites for generation of ePSTs.  The user is also 
required to provide a file name and location for the three output files that will be 
generated. 
To generate the FASTA file of the peptides to be searched, it is expected that the 
user will have performed spectral matching of their MS dataset against databases 
generated from both the proteome and the genome translated in all six reading frames and 
confirmed these peptide identifications using a peptide validation strategy.  After 
validation, the unique peptide identifications resulting from a database search against the 
genome that are not contained among the proteome peptide identifications should be used 
as the list of peptides to be searched. 
The command line version of the Proteogenomic Mapping Tool allows the same 
inputs as the GUI to be specified as command line arguments and can be run on standard 
computer platforms (Windows, Linux, Unix, MacOS).  An example of using the 




The application translates the nucleotide database to protein in all 6 reading 
frames using the genetic code selected by the user. We provide the most common genetic 
codes from NCBI [8] which are represented in NCBI’s standard format for genetic codes 
in the genetic_code_table file included with the application.  The tool maps the peptides 
to the translated genome using the Aho-Corasick string searching algorithm to provide 
rapid and exact matches of peptides to the genome [10-11].  The Aho-Corasick string 
matching algorithm [10] quickly locates all occurrences of keywords within a text string. 
 The algorithm consists primarily of two phases.  In the first, a finite state machine is 
constructed from the set of keywords.  The time to construct this machine and its memory 
requirements are linearly proportional to the sum of the lengths of the keywords.  The 
second phase consists of running the state machine using the text string as input.  This 
phase takes time linearly proportional to the length of the text string.  Thus, the time to 
run the entire algorithm is proportional to the sum of the length of the keywords and the 
length of the text string.  In our case, the peptides for which to search are the keywords, 
and the reference genome against which to search is the text string. 
 
ePST Generation 
Once a peptide has been mapped to a nucleotide sequence, the reverse translated 
peptide is used to create an expressed Protein Sequence Tag (ePST) [2]. Figure 2 
illustrates the ePST generation process for prokaryotes and Figure 3 shows both options 
for the ePST generation process in eukaryotes.  For prokaryotes, the reverse translated 
peptide is extended in the 3’ direction to an in-frame stop codon.  In the 5’ direction, the 
first in-frame stop-codon upstream of the peptide (5’ stop) is identified and the peptide is 
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extended to the first in-frame start downstream from this 5’ stop before the start of the 
peptide.  In the case that no in-frame start occurs between the 5’ stop and the start of the 
peptide, the start of the peptide is used as the start of the ePST. The process is more 
complex for eukaryotes due to splicing. For eukaryotes, the peptides can be extended to 
produce ePSTs using three different approaches.  In the first approach, the peptide is 
extended downstream to the first in-frame stop or splice site signal [12] and upstream 
until the first in-frame start, in-frame stop, or splice site signal.   We have found that this 
approach often generates ePSTs that are far longer than typical exons.  We speculate that 
this is because the potential new ORFs identified by this approach do not have a 
canonical splice site signal. While the application does default to using canonical splice 
site signals, our second approach includes the option of using predictions from 
GeneSplicer [9], a computational splice site prediction tool. The user can select to input 
GeneSplicer output for use instead of the canonical splice site signals.  A third option is 
to extend the peptide upstream and downstream by a nucleotide length specified by the 
user given as the number of codons. 
Output File Description 
Three output files are produced by the application.  The first file is a FASTA file 
containing the ePSTs generated for the dataset.   The second file is a more detailed tab 
separated text file containing the original peptide identifier from the FASTA header, the 
peptide sequence, the FASTA header for the nucleotide sequence containing the match, 
the mapping start and end locations for the reverse translated peptide, the strand of the 
nucleotide match, the reading frame of the match, the reverse translated peptide 
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sequence, a longer nucleotide sequence extending from the 5’ in-frame stop codon 
immediately upstream of the peptide to the 3’ in-frame stop codon immediately 
downstream of the peptide, the ePST nucleotide sequence and the start and stop locations 
of the ePST on the nucleotide sequence, the length of the ePST, and the translated ePST.  
The third file is a GFF3 file containing the ePSTs generated for the dataset to provide 
researchers with a file format they can quickly load into genome browsers for data 
visualization. 
Example Datasets 
To test our implementation we acquired previously published proteogenomic 
mapping datasets for a number of organisms.  For a relatively small example data set, we 
selected a proteogenomic mapping dataset for the channel catfish virus [5].  This small 
dataset contains 407 unique peptide identifications, of which 17 peptides did not map to 
the predicted proteome of the virus, but do map to novel open reading frames in the viral 
genome.  The expression of several of these genes was confirmed by RT-PCR [5].  Our 
example dataset consists of a FASTA file of these 17 peptides and the reference genome 
(NC_001493.1) for the channel catfish virus.  For bacterial examples, proteomics datasets 
from three different microorganisms [13] were used to test our application:  Histophilus 
somni strain 2236, Mannheimia haemolytica strain PHL213, and Pasteurella multocida 
strain 3480.  For a eukaryotic example, a previously published proteomics dataset 
generated from chicken serum was utilized for testing [14].  Table 1 details the number of 
unique peptides and the number of unique peptides mapping uniquely to the genomic 
database search contained in each of these five datasets. 
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Results and Discussion 
The output from the Proteogenomic Mapping Tool matches the previously 
published results against the CCV test dataset [5], and our output provides additional 
information that not only places the mapped peptides on the appropriate nucleotide strand 
but also includes the reading frame in which the match occurs.  Table 2 gives a list of the 
peptides and corresponding ePSTs for this dataset.  We have also successfully tested this 
tool for proteogenomic mapping in previously published bacterial [13] and eukaryotic 
datasets [2, 14].  Table 3 provides runtime analysis for each of our five test datasets, and 
demonstrates that the Proteogenomic Mapping Tool scales well for increasingly large 
datasets. 
Possible future updates to this application include parallelization of the searches 
against the genome in all 6 reading frames, and the introduction of better thread support 
to improve performance further on today’s modern increasingly multi-core processors. 
 
Conclusions 
The Proteogenomic Mapping Tool is a standalone program that facilitates a 
streamlined mapping of peptides to a target genome for structural genome annotation 
through the use of proteomics.  This software can be used on a variety of current 
operating systems and is its ability to use a variety of genetic codes makes it easily 
customizable for researchers performing proteogenomic mapping in a variety of 




Availability and Requirements 
Project name: The Proteogenomic Mapping Tool 
Project home page:  http://www.agbase.msstate.edu/tools/pgm/ 
Operating system(s): Windows XP, Vista (x86), Vista(x64), Linux, MacOS 
Programming languages: Java 
Other requirements: Java 
License: GNU GPLv3 [7] 
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CHANNEL CATFISH VIRUS PEPTIDES AND ePSTS. 
ID Peptide Reading Frame ePST 











































TABLE 4.2 continued 















































































TABLE 4.2 continued 

























Trypsine-4 PCSRTSGSGACSGR -1 CTGCGTAAGACGGAGGAGACCGTGCTCGCGGAC
GAGCGGTTCCGGGGCCTGCTCGGGCCGGAGATG
GTGGCACGGCTATTGAA 





Trypsine-6 LKSPPGLRK -1 CTGGAAAGGCTGAAAAGTCCACCGGGACTGCGA
AAGTGAC 




















RUNTIME ANALYSIS FOR EXAMPLE DATASETS. 
Dataset Genome Size Number unique 
peptides mapping to 
genome 
Runtime (ms) 
CCV 0.1-Mb 17 563 
H. somnus 2236 2.3-Mb 305 2,932 
M. haemolytica 
PHL213 
2.8-Mb 1,515 4,507 
P. multocida 3480 2.5-Mb 201 3,003 









Proteogenomic Mapping Tool Windows GUI.   
The proteogenomic mapping tool requires the user to provide three files and offers 
several options: 
a. Peptide Sequences File: a fasta formatted file specifying the peptide sequences for 
which to search.  
  
b. Genomic Sequences File: a fasta formatted file specifying the genome in which to 
search for the peptides.  The file can contain the entire genome as one large entry 
or multiple entries containing only selected features of interest.  For example, the 






c. Output File.  Two files will be created.  The filename provided by the user will 
contain detailed information about the mapping.  An additional fasta file with 
“.fasta” appended to the  name provided by the user will contain the ePST 
sequence in fasta format.   
 
d. ePST Generation Process:  The user is presented with four choices:  
 
1. Ignore splice sites (prokaryotes) 
 
2. Use splice sites (eukaryotes)—uses canonical splice junctions to 
terminate ePSTs. 
 
3. Use calculated splice sites (GeneSplicer output) 
 
4. Fixed distance (number of codons)—generates an amino acid sequence  
of the specified length in both the upstream and downstream direction. 
   
e. Genetic Code Table File: specifies the mapping from codons to amino acids as 
well as start and stop codons.  The genetic code table from NCBI is provided as 
the default and will typically be selected unless the user is working with an 
unusual organism.  Once the Code Tables file has been selected, the codon table 
names appearing in this file will be presented as options and the user should select 
the appropriate codon table (Standard would be used by most researchers.  If the 
user provides the name of a file a different table in NCBI format, the names of all 







Prokaryotic ePST Generation Process. 
a. Map the peptide to the translated genome. 
b. Extend the mapped peptide in the 3’ direction to an in-frame stop codon. 
c. Extend the mapped peptide in the 5’ direction to an in-frame stop codon. 
d. From this 5’ in-frame stop codon, proceed in a 3’ direction to identify an in-frame 
start codon. 
e. Final ePST. 









Eukaryotic ePST Generation Process. 
a. Options 1 and 2: Map the peptide to the translated genome. 
b. Option 1: Extend the mapped peptide in the 3’ direction to an in-frame stop codon 
or splice site boundary.  Option 2: Extend the mapped peptide in the 3’ direction 
the number of codons selected by the user. 
 
c. Option 1: Extend the mapped peptide in the 5’ direction to an in-frame stop codon 
or start codon, or splice site boundary.  Option 2: Extend the mapped peptide in 
the 5’ direction the number of codons selected by the user. 
 
d. Final ePST. 













The process of using mass spectrometry derived proteomics data for genome 
annotation is called proteogenomic mapping.  Proteogenomic mapping can make 
significant contributions to the structural annotation of genomes through the discovery of 
new functional elements, confirmation of hypothetical and predicted functional elements, 
corrections to the intron/exon boundaries of known functional elements, and 
characterization and discovery of alternative splice forms.  We use serum proteins 
derived from Gallus gallus (chicken) and mass spectrometry for proteogenomic mapping 
of expressed peptides to the chicken genome to improve structural annotation.  We 
confirm the expression of 268 proteins from chicken serum and identify an additional 47 
peptides that confirm the expression of mRNA, identify novel exons or genes, indicate 




Structural genome annotation is the process of identifying all of the structural 
elements that comprise an organism’s sequenced genome.  These structural elements can 
include regions that code for proteins, both coding and non-coding RNAs, regulatory 
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regions, and DNA binding motifs.  Traditionally, this has been accomplished through the 
use of expressed sequence tags (ESTs) and cDNA libraries (transcribed RNA that is 
reverse translated into DNA sequences).  These ESTs and cDNAs generally represent 
approximately 500-800 base pair mRNA sequences that are sequenced as mRNA, or 
translated back into cDNA and then sequenced [1, 2].  These EST and cDNA libraries are 
then aligned with the sequenced genome to identify regions representing exons and whole 
genes that are actively transcribed [1, 2]. 
These methods are traditionally complemented by the use of computational gene 
finders that utilize the EST and cDNA libraries and the sequenced genome to identify 
patterns within the genome indicative of coding regions.  This is known as homology 
based computational annotation [1, 2].  Additionally, these programs can perform de 
novo based genome annotation where they detect signal information within the genome 
and use these signals to predict coding regions [1].  These computational gene prediction 
tools produce a number of errors, and significant resources are dedicated to identifying 
and correcting these errors within the genome annotation [1, 3].  It is estimated that the 
exact genomic structure is only correctly identified by computational gene finders 50-
60% of the time within the human genome, the most well sequenced and annotated 
genome [3].  These errors can arise from a number of causes.   Homology based 
annotation identifies new genetic sequences based on their similarity to known gene 
sequences through a combination of similarity information with signal information, and 
while these methods are very good at identifying new genes similar to known genes, they 
are limited when given a signal with no similarity information [1].  Several well-known 
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tools implement a homology based approach to computational gene finding including 
INFO, ICE, AAT, SYNCOD, EbEST, Est2genome, TAP, PAGAN, DIALIGN [1].  De 
novo based annotation methods typically use signal information identified through the 
use of Hidden Markov Models (HMMs) to predict genes, and a number of tools utilize 
this approach including Genscan, Genie, GeneMark.hmm, and FGENESH [1].  Several 
issues can affect the accuracy of these de novo prediction algorithms and give rise to 
errors including large genes, large introns, highly conserved introns, small exons, 
overlapping genes, polycistronic gene arrangement, frameshifts, and alternative splice 
sites [1]. 
In addition to these traditional structural genome annotation methods, the use of 
high throughput shotgun proteomics data derived from mass spectrometry experiments is 
increasingly being used as a complementary method for structural genome annotation [4].  
This use of proteomics data to aid in genome annotation was first reported in 2001 [5] for 
several prokaryotic projects, and was popularized in 2004 by Jaffe et al., who coined the 
term proteogenomic mapping [6].  Proteomic evidence, identified as expressed Protein 
Sequence Tags (ePSTs), provides proof that a given gene is expressed, and when back 
translated and aligned with the sequenced genome, provide structural annotation 
information for a genome’s functional elements [4, 7].  This can include “confirmation of 
translation, reading-frame determination, identification of gene and exon boundaries, 
evidence for post translational processing, identification of splice-forms including 
alternative splicing, and also, the prediction of completely novel genes” [4].  
Proteogenomic mapping has been utilized in a number of both prokaryotic [5, 6, 8-14] 
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and eukaryotic [15-26] genome annotation projects, and is increasingly becoming a part 
of standard annotation pipelines utilizing multiple sources of evidence (sequenced nucleic 
acids, computational gene prediction, and proteomics data) [2].  
 
Prokaryotic Proteogenomic Mapping 
 
Much prior work in proteogenomic mapping has been done in prokaryotic 
genome annotation projects [5, 6, 8-14]. These prokaryotic genomes have relatively 
simple genome structures compared to eukaroytic genomes. Unlike eukaryotes, 
prokaryotes do not have an intron-exon gene structure nor are they subject to alternative 
splicing [5]. In addition, these prokaryotic genomes are significantly smaller than 
eukaryotic genomes, and this small genome size compared to that of eukaryotes allows 
for direct searching of spectral databases made up of peptides generated from the genome 
sequence translated in all six reading frames [5].  Table 5.1 shows a comparison of 
genome sizes for selected prokaryotic and eukaryotic genomes. 
 
Eukaryotic Proteogenomic Mapping 
 
While eukaryotic proteogenomic mapping projects began shortly after their 
prokaryotic counterparts [15-18, 20, 22, 23], the complications arising from the larger 
and more complex genome structure  has prevented proteogenomic mapping from 
becoming a significant part of genome structural re-annotation projects in eukaryotes 
until recently [19, 21, 24-26].  These differences in eukaryotic genome structure 
compared to prokaryotic genomes arise from the intron-exon structure of genes, repetitive 
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regions of the genome, gene duplications, splicing and alternative splicing events, and the 
large areas of intergenic DNA [5]. 
A number of different approaches for constructing and searching databases of 
peptide spectra have been developed to address the challenges of using proteomics for 
genome annotation in eukaryotes.  One of the simplest approaches is to search spectra 
against the genome in its entirety or against selected chromosomes in the genome of 
interest [15].  A modification of this method is to break the genomes into large chunks of 
nucleotides with each chunk having some overlap regions with the adjacent chunks  [17, 
20, 23].  In 2005, Kalume identified 50 novel transcripts and one novel gene in Anopheles 
gambiae (mosquito) using this method [23], while McCarthy (2006) used this method to 
identify 521 potential novel proteins from the Gallus gallus (chicken) “unassigned 
chromosome”.  The “unassigned chromosome” represents 10-11% of the chicken genome 
and is composed of sequences not mapped to the genome assembly [22].  In 2006, 
Fermin generated a database composed of all ORFs from the Homo sapiens genome, and 
utilized that for DB searches, identifying 282 significant ORFs with 627 novel peptides 
[18].  In 2007, Tanner utilized computational gene prediction software to identify exons 
within the Homo sapien genome and then constructed exon-splice graphs, which for a 
given gene take the starting exon and construct sequences by mapping it to all possible 
internal exons in order to represent alternative splice forms [21].  Using this method, they 
identified 16 novel genes and extended exons, while confirming over 40 alternate 
splicing events [21].  Some eukaryotic projects have used the de novo sequencing of 
peptides instead of a database search, and then used these de novo identifications to 
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search genome sequences with BLAST in order to identify regions that code for proteins 
[16].   
 More recently, several of these approaches have been combined or coupled with 
changes to spectral generation protocols by various research groups for more 
comprehensive proteogenomic mappings [19, 24, 25].  In an application of 
proteogenomic mapping to the Arabidopsis thaliana genome, Castellana (2008) 
constructed three separate databases: the proteome database, a database comprised of 
exon-splice graphs, and the genome translated in all six reading frames. Using this multi-
database approach, they identified 778 new protein coding genes and refined the 
annotation of 695 gene models [19].  In a proteogenomic mapping project with 
Caenorhabditis elegans , Merrihew (2008) constructed databases for the proteome, 
predicted genes from a computational gene finder (GeneFinder) not contained within the 
proteome database, and the intergenic regions that shared a high homology with 
Caenorhabditis briggsae, a closely related species [25].  Searching against these 
databases, they identified 429 new coding sequences not present in the known proteome, 
33 of which were predicted pseudogenes and 245 of which were novel genes [25].  In 
2008, Sevinsky combined isoelectric focusing of peptides subjected to mass spectrometry 
with databases constructed from a six frame translation of each contig of the Homo 
sapiens genome.  These databases were in silico trypsin digested and the in silico 
peptides were sorted by molecular weight (MW) and isoelectric point (pI) [24].  These 
were further separated by splitting the in silico peptides into separate databases for every 
0.01 pI interval.  These were further separated into genic and intergenic databases [24].  
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Experimental spectra from a given pI range were then searched against the corresponding 
database, and this methodology yielded 540 genome specific peptides that had no 
matches against the human proteome [24]. 
 
Gallus gallus Proteogenomic Mapping 
 
The Gallus gallus (chicken) genome draft sequence was released in 2004, and is 
approximately 1,200 Mbp with ~20,000 to 22,000 genes [27].  The most current build is 
Build 2.1, released in November 2006, and has a 6.6X coverage with 95% of the genome 
anchored to chromosomes.  The chicken genome contains 38 pairs of autosomal 
chromosomes and 2 sex chromosomes (Z and W) [27].  Of the 38 autosomal 
chromosomes, 33 are classified as microchromosomes and these microchromosomes 
have a very high gene density [28].  A large portion of the unsequenced genome resides 
on the microchromosomes and this results in ~5-10% of the predicted chicken genes 
being absent from the Ensembl gene set [27].  Chicken represents an important 
agricultural species, has a long history as an important medical model,  serves as the 
avian model organism, and it is an important vertebrate outlier on phylogenetic trees 
because of its evolutionary distance (~310 million years) from mammalian species [27].    
While the build number of the chicken genome is low compared to that of human 
and mouse, there are similar numbers of predicted proteins, but many fewer ESTs are 
available to aid in the structural annotation.  We have used mass spectra from chicken 
serum to improve structural annotation of the chicken genome.  We also address methods 
for database organization to obtain a significant number of peptide spectra matches when 
searching against databases derived from genetic sequences. 
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Results and Discussion 
 
Our initial proteogenomic mapping experiments with several previously published 
chicken mass spectral datasets using a decoy database search strategy resulted in very 
few peptides that were unique to the genome when spectra were identified using searches 
against to the genomic database.   Our decoy databases for the proteome and genome 
were derived using Markov chains based on the chicken proteome and the chicken 
genome respectively. Further investigation of the Δ CN and XCorr quality scores from 
the Sequest searches against the proteome and genome revealed that there were many 
high scoring peptide matches against the proteome, but very few high scoring matches 
against the genome as illustrated in Figure 5.1.  Similar results were obtained for a 
chromosome relatively poor in serum protein genes (chr 6) and a chromosome relatively 
rich in serum protein genes (chr 3).  Therefore we investigated different database 
construction approaches.  
Since the size of the genome database is more than six times the size of the 
proteome database, we conducted an experiment to determine if the loss in peptide 
identifications against the genome was a function of database size. For this experiment, 
the proteome database was concatenated with increasing amounts of decoy random 
amino acid sequence to serve as the proteome database.  Decoy databases of the same 
size were also generated and these databases were used to search for PSMs.  Figure 5.2 
shows the effects of database size on the number of peptides identified.  The number of 
peptides identified against the proteome was used as a baseline and is indicated by zero 
on the x-axis (zero added decoy sequence) and one on the y-axis.   Decoy amino acid 
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sequence was progressively added to the proteome in increments the same size as the 
proteome.  Thus, a value of two on the x-axis means that the database was three times as 
large (proteome + 2x decoy) as the original proteome database.    We noted a significant 
decrease in the peptide identifications as the number of spectra from decoy sequence 
increased. As Figure 5.2 indicates, there is substantial difference in the loss of peptide 
identifications among different datasets indicating differences in the quality of the mass 
spectra.  Because these poor quality spectra are not robust to the addition of noise, they 
are not useful for proteogenomic mapping.  This process of iteratively adding “noise” to 
the proteome and conducting searches provides a method for determining if spectra are of 
sufficiently high quality for proteogenomic mapping.  As shown in Figure 5.2, the new 
serum proteomics dataset used for this study (collected using updated methodologies and 
equipment) is substantially more robust to the addition of noise than the older datasets.  
 The influence of database size on results obtained when searching against the 
genomic sequences translated in 6 reading frames also led us to use separate databases for 
genic and intragenic regions.  In order to maintain a one-to-one relationship between the 
number of proteins in our protein database and the number of genes in our genic 
database, we constructed all three of our databases (proteomic, genic, and intragenic) 
based on the chicken proteins in the International Protein Index (IPI) database, which 
provides “minimally redundant yet maximally complete sets of proteins for featured 
species” [29].   Our genic database was generated by locating the gene sequences 
corresponding to proteins found in the IPI database, and extracting the DNA sequence 
including introns plus 5’ and 3’ UTR sequence from the sequenced genome.  Since the 
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lengths of the 5’ and 3’ UTR sequences have not been determined experimentally for 
most chicken genes, we used   5’ and 3’ UTR lengths based on the mean lengths for 
Homo sapiens [30]).  Peptides were identified using the Sequest spectral matching 
algorithm [31] by searching against our three databases and validated using a target-
decoy database search strategy.  Peptides with a p-value of less than 0.05 were considered 
valid identifications.  Peptides identified by searching against the genic or intergenic 
databases  but against the proteome database were analyzed with the Proteogenomic 
Mapping Tool [32] to generate the reverse translated (RT) sequences for each of the 
peptides by mapping each of these RT peptides back to locations within the chicken 
genome. 
 Our searches against the IPI Gallus gallus proteome database identified 268 
proteins comprising the serum proteome.  These proteins were identified by 8,797 
peptides (960 unique peptides).  We also identified 2,993 peptides when searching 
against our genic database.  Of these 2,933 genic peptides, 2,742 were present in the 
results of the proteome search, resulting in 251 peptides (represented by 48 unique 
peptides) matching the genic database but not the proteome database.  After examination 
of these peptide sequences, we identified 4 peptides in this dataset which were digests of 
peptides present in the results of the proteome DB search.  This resulted in the 
identification of 44 unique peptides that map to the genic database but not to the 
proteome.   Ten of these genic peptides were mapped into proteins identified by different 
proteomic peptides through our search of the proteome database.  Searches against the 
database composed of intragenic regions yielded three unique peptides. 
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The ten unique peptides identified from our genic database search that also have 
corresponding evidence for expression from our proteome database search are shown 
mapped to the genome in Figures 5.3 - 5.6.  Figure 5.3 shows an instance where a peptide 
maps to a chicken EST within the 5’ UTR of an IPI protein similar to α-2-macroglobulin 
(IPI00599918) curated proteins on the same strand (aqua track).  The peptide aligns with 
the NCBI gene model for this protein, but not the Ensembl gene model.  Since the IPI 
proteins are heavily derived from the Ensembl gene models, this peptide was not present 
in the proteome database we performed our proteome search against, but we did observe 
several hits of different peptides against the proteome database for the IPI/Ensembl 
model, indicating the NCBI model is more accurate.  Figure 5.4 shows six peptides 
mapping on the same strand to regions within the Immunoglobulin (IG) Lambda Chain 
Variable-1 Region in a region of high translation expression. 
Some of these peptides have no exon or EST evidence, and we hypothesize that we are 
observing a sufficiently sensitive proteogenomic mapping to pick up the splicing changes 
in the exons of IG variable regions as part of the synthesis of immunoglobulin.  Figure 
5.5 shows a single peptide mapping to the 5’ UTR of serum albumin (IPI00574195).  
Many peptides matching the proteome database confirm the expression of serum 
albumin. Given that this peptide is on the same strand as serum albumin, it is indicative 
of a potential new exon or gene..  Figure 5.6 shows a peptide mapping to the same strand 
as the 5’ UTR of an uncharacterized protein (IPI00821912) which we identified as 
expressed through our searches of the proteome database.  This peptide maps to a chicken 
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EST in this region, providing proteomic evidence confirming expression of the EST, and 
a possible correction of the annotation information for this uncharacterized protein.  
The remaining 34 genic and 3 intragenic peptides can be divided into five groups 
based on where they map within the genome: 
1. Peptide confirming protein expression 
2. Peptide confirming exon from mRNA  
3. Peptide indicating novel exon or gene 
4. Peptide correcting exon boundary 
5. Peptide in or near a repeat region 
Figures 5.7 through 5.11 show examples of each of these groups.  In Figure 5.7 two 
reverse translated (RT) peptides not seen in the set of peptides identified with the 
proteome database are shown.  The genomic peptide IPI00579242 maps on the same 
strand as a gene model present in both the NCBI/Ensembl gene sets confirming protein 
expression, and providing evidence of a potential new exon within this protein.  The 
second genomic peptide, IPI00580765 is shown mapped into a region between two genes 
in both the NCBI/Ensembl protein sets along the same strand indicative of a potential 
new small gene or exon in this region.  Figure 5.8a shows an RT peptide confirming an 
NCBI gene where there is no Ensembl gene in the area and Figure 5.8b shows the same 
peptide using the UCSC genome browser confirming multiple mRNA evidence for an 
exon in the indicated region.  Notably, the gene model from NCBI identified in a) is not 
indicated as having a higher confidence RefSeq gene model by b), meaning there is not a 
curated gene model for this gene in the NCBI database.  Figure 5.9 a) shows 3 distinct 
RT peptides mapping to a novel chicken exon or gene while b) shows the same three 
peptides visualized with the UCSC genome browser in order to gain the conservation 
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track.  These peptides are shown to map to an area of high conservation, providing 
evidence of a novel chicken exon or gene in this area. Figure 5.10 a) shows an RT 
peptide expressed within a known gene model along the same strand, near an exon and 
two repeat elements.  Figure 5.10 b) shows this same peptide using the UCSC genome 
browser clearly mapping to a repeat region within the genome identified by 
RepeatMasker.  Figure 5.11 a) shows an RT peptide that corrects an exon boundary in the 
structural annotation of the chicken genome of an Ensembl gene.  It maps to the same 
strand to the edge of a known Ensembl gene, and b) shows that the peptide maps to a 
region of conservation at the 3’ end of this gene model.  There is no NCBI gene model 




 We have confirmed the expression 268 serum proteins from our Gallus gallus 
proteome database.  The 47 remaining peptides that map uniquely to the genic and 
intragenic regions of the Gallus gallus genome were used to improve the structural 
annotation by confirming 2 exons predicted by mRNA, providing evidence of 17 novel 
exons or genes, showing evidence of the expression of 7 repeat regions, and providing 4 
corrections to the boundaries of known exons.  These peptides serve as a complementary 
method to traditional structural annotation methodologies, and for model organism 
genomes like chicken, that do not undergo the same level of refinement as human or 




The use of proteogenomic mapping as a tool to aid in the structural annotation of 
genomes shows that even the most up-to-date de novo or homology based computational 
gene prediction misses or incorrectly annotates a number genes.  Additionally, 
proteogenomic mapping provides proof that a given protein is actually translated and 
expressed in a tissue as opposed to the evidence of translation obtained using massively 
parallel next-generation sequencing technologies.  As mass spectrometry techniques 
improve and the speed of matching spectra to peptides increases due to both improved 
algorithms and increased computational power, proteogenomic mapping should be 
increasingly utilized to provide and confirm structural annotations of eukaryotes. 
Future work should focus on identifying areas of the genome where there is 
discrepancy between the NCBI and Ensembl gene model datasets and identifying 
peptides identified as expressed from those areas as part of an effort to improve 
computational tools for gene prediction.  Additionally, efforts to include peptides with a 
lower probability of expression when identified using a decoy database strategy could be 
incorporated by anchoring regions with high probability expression peptides and then 
including lower probability peptides locally.  Alternatively, our strategy of constructing 
the genomic database based on the protein database and not searching raw genomic 
sequence or performing extensive experimental manipulations allows regions were 
protein expression is observed to be easily identified and potentially used for construction 
of smaller databases supporting stepwise searches.  When combined with an anchoring 
method, this could potentially provide higher coverage of peptides to the genome from a 




Methods and Materials 
 
 
Mass Spectrometry Datasets 
 
The initial Gallus gallus serum MS dataset used is described in [33]  and the 
Gallus gallus bursa MS dataset used for Figure 5.2 is described in [22]. For the updated 




Serum was collected from clotted whole chicken blood in inverted 3 cc/mL 
syringes.  Serum was aliquoted, clarified (1000 rpm, 5 min, 4 °C) and protein yield was 
determined using the Pierce BCA Protein Assay Kit (Fisher Scientific, Pittsburgh, PA).  
One-dimensional (1-D) gel electrophoresis was performed on serial dilutions of the 
serum (1:2, 1:10, 1:25)(Criterion Gel System, Bio-Rad, Hercules, CA).  Gels were 
stained with Coomassie Blue (Processor Plus, Amersham Biosciences, Piscataway, NJ) 
and documented (FluorChem SP, Alpha Innotech, San Leandro, CA). 
 
Trypsin Digestion 
In-gel and in-solution tryptic digestions on the serum were done in parallel for 
protein coverage comparison (43.4 μg protein were used).  Prior to in-gel tryptic 
digestion, the lane representing the 1:10 dilution was selected and divided into 5 
fractions:  group 1 (darkest bands), group 2 (medium bands), group 3D (darkest light 
areas between bands), group 3M (medium light areas) and group 3L (lightest light areas).  
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Gel fractions were destained (50 mM NH4HCO3/50 % acetonitrile, 10 min), dehydrated 
(100 % acetonitrile, 15 min), reduced (10 mM DTT 30 min), alkylated (55 mM 
iodoacetamide, 20 min), dehydrated (100 % acetonitrile, 3 × 5 min), rehydrated (50 mM 
NH4HCO3, 10 min) and trypsin-digested (10 µg, O/N, Promega, Madison, WI).  All steps 
were done at 35-37 °C.  Peptides from the fractions were extracted (1%  TFA, 2% 
acetonitrile, 2 × 30 min; the second time with 100 % acetonitrile).  For the in-solution 
tryptic digestions, aliquots (10 μL) of the 1:10 dilution were reduced (5 mM DTT, 5 min, 
65 °C), alkylated (10 mM iodoacetamide, 30 min, 37 °C) and trypsin-digested (1 μg, 
O/N, 37 °C, Promega, Madison, WI).  All in-gel and in-solution tryptic digests were 
vacuum centrifuged until dried completely (Savant SPD2010, Thermo Electron, Milford, 
MA) and resuspended in 0.1 % formic acid.  Digests from groups 3D, 3M and 3L were 
pooled, vacuum centrifuged and resuspended in 0.1 % formic acid. 
 
Sample Cleanup 
After digestion, samples are adjusted to 2% Acetonitrile and each is desalted 
using a peptide macrotrap (Michrom TR1/25108/52) according the manufacturer’s 
instructions.  Following desalting, samples are cleaned using a strong cation exchange 
(SCX) trap (Michrom TR1/25108/53) according to the manufacturer’s instructions to 
remove detergents or other polymers which can interfere with MS/MS analysis.  All 
samples were then dried and resuspended in 20 µl of 5% Acetonitrile, 0.1% Formic Acid 
and transferred to a low retention autosampler vial for deconvolution via reverse phase, 






Each sample was loaded on a BioBasic C18 reversed phase column (Thermo 
72105-100266) and flushed for 20 min with 5% acetonitrile (ACN), 0.1% formic acid to 
remove salts.  Peptide separation was achieved using a Thermo Surveyor MS pump with 
a 655 min nano-HPLC method consisting of a gradient from 5% ACN to 50% ACN in 
620 min, followed by a 20 minute wash with 95% ACN and equilibration with 5% ACN 
for 15 minutes (all solvents contain 0.1% formic acid as a proton source).  Ionization of 
peptides was achieved via nanospray ionization using a Thermo Finnigan nanospray 
source type I operated at 1.85kV with 8 micrometer internal diameter silica tips (New 
Objective FS360-75-8-N-20-C12).  High voltage was applied using a t-connector with a 
gold electrode in contact with the HPLC solvent.   A Thermo LCQ DECA XP Plus ion 
trap mass spectrometer was used to collect data over the 655 minute duration of each 
HPLC run.   Precursor mass scans were performed using repetitive MS scans, each 
immediately followed by three MS/MS scans of the three most intense MS peaks.  
Dynamic exclusion was enabled with a duration of two minutes and a repeat count of 
two.  
Protein Identification   
Database searches were performed using the SEQUEST algorithm [34] in 
Bioworks 3.3 (Thermo Finnigan).  The proteome database for peptide spectral matching 
was the Gallus gallus IPI protein database (version 3.56) [29].  Search results were 
filtered using a decoy based, distance-based outlier detection method in which a 
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probability of being a false positive match is assigned to each peptide [35].  The decoy 
database was constructed using a 0
th
 order hidden Markov model based on the amino acid 
distribution of the proteome.  Proteins with a probability of differential expression of 0.05 
or less were selected for further modeling.  Two different databases for peptide spectral 
matching against the genome were constructed based on the Gallus gallus IPI protein 
database (version 3.56).  The first database contains the genetic sequences of all the 
proteins contained within the IPI protein set including introns and 5’ and 3’ regulatory 
regions [30], and the second database contains all the remaining intragenic regions not 
contained in the first database.  Decoy databases were constructed using a 5
th
 order 
hidden Markov model based on the nucleotide distribution in each of these two databases. 
Proteogenomic Mapping 
 
Custom Perl scripts were used to identify peptides with unique peptide spectral 
matches to the genomic databases and these peptides were mapped onto the chicken 
genome using the Proteogenomic Mapping Tool, a Java based tool which implements the 
Aho-Corasick string mapping algorithm for proteogenomic mapping in both prokaryotes 
and eukaryotes [32].  The resulting output was then visualized using Gbrowse [36, 37] 
and the UCSC Genome Browser [38], and GFF3 files were also generated for use with 
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Channel catfish herpesvirus 
(CCV) 0.13 [11] 
Mycoplasma mobile 0.78 [8] 
Mycoplasma pneumonia 0.8 [5] 
Haemophilus influenzae 1.8 [5] 
Porphyromonas gingivalis 2.2 [5] 
Haemophilus somnus 2.3 [13] 
Pasteurella multocida 2.5 [13] 
Mannheimia haemolytica 2.8 [13] 
Geobacter lovleyi 3.9 [10] 
Geobacter bemidjiensis 4.6 [10] 
Yersinia pestis 4.7 [14] 
Rhodopseudomonas 
palustris 5.5 [9] 
Arabodopsis thaliana ~125 [19] 
Caenorhabditis elegans ~100 [25] 
Tetrahymena thermophila ~102 [17] 
Anopheles gambiae ~278 [23] 
Gallus gallus ~1500 [22] 
Danio rerio ~3112 [26] 


















Initial Comparision of Peptide Spectra Matches Against the Proteome and Gallus gallus 
Chromosome 6. 
a) Gallus gallus Proteome Target-Decoy Analysis 







Loss In Shared Peptide Identifications 
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A Peptide Confirming Protein Expression and Possible Novel Exon and a Peptide 











































The increasing volumes of genomic, transcriptomic and proteomic data available 
has resulted in the need for rapid analytical techniques that derive information from that 
data.  This dissertation addresses the application of machine learning algorithms to 
proteomics problems.  This chapter summarizes each project and  evaluates the research 
as a whole.  We have shown that it is possible to predict experimentally observable 
properties of peptides using machine learning classifiers and that the application of mass 




Prediction of Peptides Observable by Mass Spectrometry 
 
Chapter II describes a procedure for constructing an artificial neural network 
classifier to predict which tryptic peptides in a protein are likely to be detectable by mass 
spectrometry for a specific set of experimental and instrumental conditions.  We 
demonstrate that it is possible to construct a classifier with accuracy comparable to those 
previously reported based on the accumulation of large training sets from multiple 
experiments.  We also show that a classifier constructed based on one dataset does not 
perform at an acceptable level when predicting observability for another dataset and thus 
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it is necessary to construct  classifiers that are specific for one set of experimental 
conditions. The resulting classifier provides researchers with a tool that can provide 
information about peptide coverage of proteins in terms of which proteins are likely to be 
detectable.  It can also be used as one line of evidence in a systems analysis to evaluate 
alternative hypotheses concerning proteins that were not observed but that were expected.  
If the “missing” protein generates many predicted detectable peptides but none were 
observed, then this provides additional probabilistic evidence of absence of the protein—
a very difficult hypothesis to demonstrate conclusively.   The classifier allows researchers 
to distinguish between proteins that are not likely to be detected with the methodology 
versus proteins that were not expressed in the biological system and to thus improve 
biological modeling. 
 
Prediction of Cell Penetrating Peptides 
 
We have identified sets of known cell penetrating peptides and non-penetrating 
cell penetrating analogs from the literature and use these to construct a number of 
different datasets to address the problem of imbalance between the number of positive 
and negative examples.  Utilizing these datasets, we show that it is possible to obtain a 
higher than previously reported accuracy for the prediction of cell penetrating peptides 
using support vector machines as opposed to previous methods utilizing a method based 
on determining if the average score of a peptide falls within a range of features 
determined through the use of principle component analysis.  We then generate a number 
of peptides based on the amino acid distribution of the chicken proteome and classify 
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these peptides as either cell penetrating or non-cell penetrating based on the predictions 
of our classifiers.  These peptides along with positive and negative experimental controls 
were synthesized and analyzed for cell penetration using two avian cell lines.  Our 
classifiers accurately predict cell-pentrating potential, and we have identified a lack of 
negative examples of cell penetrating peptides in the literature.  Additionally, we have 
noted that the cell type being used for the evaluation of cell penetrating potential should 
be included as a predictive feature in future studies as peptides previously predicted to be 
penetrating or non-penetrating in previous studies using a specific cell line might not be 
accurate for alternative cell lines. 
 
 
Proteogenomic Mapping of Chicken Serum 
 
We have confirmed the expression 268 serum proteins from our Gallus gallus 
proteome database.  The 47 remaining peptides that map uniquely to the genic and 
intragenic regions of the Gallus gallus genome were used to improve the structural 
annotation by confirming 2 exons predicted by mRNA, providing evidence of 17 novel 
exons or genes, showing evidence of the expression of 7 repeat regions, and providing 4 
corrections to the boundaries of known exons.  These peptides serve as a complimentary 
method to traditional structural annotation methodologies, and for model organism 
genomes like chicken, that do not undergo the same level of refinement as human or 




The use of proteogenomic mapping as a tool to aid in the structural annotation of 
genomes shows that even the most up-to-date de novo or homology based computational 
gene prediction misses or incorrectly annotates a number genes.  Additionally, 
proteogenomic mapping serves provides proof that a given protein is actually translated 
and expressed in a tissue as opposed to the evidence of translation obtained using 2
nd
 
generation sequencing technologies.  As mass spectrometry techniques improve and the 
speed of matching spectra to peptides increases due to both improved algorithms and 
increased computational power, proteogenomic mapping should be increasingly utilized 
to provide and confirm structural annotations of eukaryotes. 
Future work should focus on identifying areas of the genome where there is 
discrepancy between the NCBI and Ensembl gene model datasets and identify any 
peptides identified as expressed from those areas as part of an effort to improve 
computational tools for gene prediction.  Additionally, efforts to include peptides with a 
lower probability of expression when identified using a decoy database strategy could be 
incorporated by anchoring regions with high probability expression peptides and then 
including lower probability peptides locally.  Alternatively, our strategy of constructing 
the genomic database based on the protein database and not searching raw genomic 
sequence or performing extensive experimental manipulations allows regions where 
protein expression is observed to be easily identified and potentially used for construction 
of smaller databases to search against in a stepwise manner.  When combined with an 
anchoring method, this could potentially provide higher coverage of peptides to the 





In Chapter II, we have shown that it is possible to predict the peptides observable 
by mass spectrometry using neural networks for a single dataset in contrast to other 
prediction methods utilizing large datasets compiled from a number of different 
experimental techniques.  Since the research presented in that chapter was conducted and 
published, methods for statistically validating peptides from mass spectrometry derived 
datasets have changed to provide a more statistical basis for determining which peptides 
are valid hits against a target proteome database.  Given these changes, future work in 
predicting peptides observable by mass spectrometry could explore different strategies 
for training dataset construction methodologies.  Additionally, to obtain a better 
understanding of which properties contribute to the prediction of flyability could be 
obtained by analyzing the same proteomics mixture using a variety of digestion enzymes 
in addition to trypsin while holding the LC-MS conditions constant.  The entire database 
of theoretical spectra could be analyzed to determine which peptides are proteotryptic, 
reducing the size of the database to be searched against, and increasing the effectiveness 
proteogenomic mapping for organisms with large genomes. 
The research presented in Chapter III shows that machine learning algorithms 
using individual biochemical properties for features instead of composite features derived 
from principle component analysis can accurately predict whether or not a given peptide 
is capable of cell penetration.  The small amount of data available for constructing 
training and testing datasets were discussed, and demonstrates the critical need for a 
curated database of peptides shown to penetrate or not penetrate a given cell type.  
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Additionally, future research should focus on compiling sets of non-penetrating analogs 
of cell penetrating peptides to increase the number of difficult to predict negative 
examples and to aid in the improvement of the prediction accuracy of classifiers.  
Additionally, once individual cell types are included in the features used for prediction of 
cell penetration, various features such the lipid composition of the cell membranes of 
various cell lines could be included to aid in prediction and help provide better 
understanding of the mechanism of cell penetration for that cell type. 
Computational chemistry has provided software packages to analyze the 
quantitative structure and activity relationships (QSAR) of molecules, and these QSAR 
features were shown by Dobachev et al. [1] to aid in the prediction of cell penetrating 
peptides, and could be combined with the basic biochemical properties we utilize for 
features to improve the prediction accuracy of our classifiers for the prediction of flyable 
peptides and cell penetration. 
Chapter IV presents a tool for taking peptides observed via mass spectrometry and 
mapping them back to the genome in a fast and accurate manner in order to help improve 
the structural annotation of genomes.  In Chapter V we utilize this method along with 
various methods for assessing dataset quality and database construction to take peptides 
observed from the serum of the domestic chicken and use them for proteogenomic 
mapping to improve the structural annotation of the chicken genome.  We show that 
proteogenomic mapping is sufficiently sensitive to identify variations in splicing events 
used to produce various immunoglobulin isoforms, and identify corrections to 
intron/exon boundaries in predicted genes, and identify novel genes and exons not 
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identified by traditional structural genome annotation methods.  As more eukaryotic 
proteogenomic mapping projects make progress, these novel genes, exons, and boundary 
corrections should be incorporated in general gene models for improved gene predictions 
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